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ABSTRACT
Vibrio anguillarum is an extracellular bacterial pathogen that is a causative agent
of vibriosis in finfish and crustaceans. Mortality rates range from 30% to 100% and
systemic infection usually causes fish to die within 1-4 days of initial infection. The
primary routes of infections are through the skin, gills and intestines. Chemotactic
motility and the metalloprotease EmpA have been shown to be important virulence
factors during the invasion stage while the siderophore anguibactin, flagellin subunits and
lipopolysaccharides were shown to be important for persistence in the host during the
post-invasion stage. Three secreted proteins that are cytotoxic against epithelial cells and
erythrocytes have been characterized in V. anguillarum: the HlyA homolog Vah1, the
phospholipase Plp, and the MARTX toxin RtxA. Previous research has demonstrated that
mutations in vah1 and/or plp resulted in slight attenuation against juvenile Atlantic
salmon (Salmo salar); however, rtxA mutants were avirulent. Expression of the
cytotoxins are under control of the transcriptional activator HlyU and the repressor H-NS.
Additionally, a V. anguillarum hns mutant showed attenuation in virulence when injected
intraperitoneally, suggesting that proper coordination of gene expression is an important
factor during the post-invasion stage.
In manuscript I “Isocitrate dehydrogenase mutation in Vibrio anguillarum results
in virulence attenuation and immunoprotection in rainbow trout (Oncorhynchus mykiss)”,
seven central metabolism mutants were created in the M93Sm strain and characterized
with regard to growth in minimal and complex media, expression of virulence genes and
virulence in juvenile rainbow trout. Only the isocitrate dehydrogenase (icd) mutant was
attenuated in virulence against rainbow trout challenged by either intraperitoneal

injection or immersion. Further, the icd mutant was shown to be immunoprotective
against wild type V. anguillarum experimental challenge. The icd mutant did not
demonstrate a significant decrease in the expression of the three hemolysin genes was
detected by qRT-PCR. Only the icd mutant exhibited a significantly decreased growth
yield in complex media that was directly related to the amount of glutamate. A strain with
a restored wild type icd gene was created and shown to restore growth to a wild type cell
density in complex and minimal media and pathogenicity in rainbow trout. The data
strongly suggest that a decreased growth yield, resulting from the inability to synthesize
α-ketoglutarate derivatives (glutamate and glutamine), caused the attenuation despite
normal levels of expression of virulence genes. Therefore, the ability of an extracellular
pathogen to cause disease may be dependent upon the availability of host-supplied
nutrients for growth.
In manuscript II “Characterization of the growth and virulence of a Vibrio
anguillarum citrate synthase mutant”, the role of glutamate auxotrophy during V.
anguillarum M93Sm infection was further characterized. A citrate synthase (gltA)
deletion mutant was created and characterized with regard to growth in minimal and
complex media, expression of virulence genes, and virulence in juvenile rainbow trout.
The ΔgltA mutant exhibited a decreased final cell density when grown in LB20 that
resulted from the exhaustion of glutamate from the media. There was no significant
decrease in the expression of the three hemolysin genes by the ΔgltA mutant when
detected by qRT-PCR or mortality during challenge experiments. A ΔgltA mutant
capable of growing in minimal media was isolated and shown to have a spontaneous
mutation in the transcriptional activator of 2-methylcitrate synthase (prpR). This mutation

resulted in an increase in expression of 2-methylcitrate synthase (prpC). The ΔgltA
prpR(R66L) mutant was characterized with regard to growth in complex media and
exhibited a growth advantage compared to the ΔgltA mutant after 24 h in spleen extract
medium. Further, after growing 120 h in spleen extract medium, colonies of ΔgltA
mutants were shown to be capable of growing in minimal media. ΔprpC and a ΔgltA
ΔprpC mutants were created and characterized with regard to growth in minimal and
complex media and virulence in juvenile rainbow trout. The ΔgltA ΔprpC mutant had no
growth advantage in spleen extract medium compared to the ΔgltA but was still as
virulent as the wild type against rainbow trout. As expected, the ΔprpC mutant was
similar to the wild type in regards to both growth in minimal and complex media and
virulence against rainbow trout. The data strongly suggests that simple starvation for αketoglutarate derivatives (glutamate and glutamine) is not directly linked to attenuation of
virulence as previously proposed. Additionally, spontaneous mutations can occur that
compensate for the original gene deletion if the new mutation can replace or bypass the
lost metabolic reaction and results in a growth advantage.
In manuscript III “Characterization of Vibrio anguillarum NB10Sm TCA cycle
mutants” the role of central metabolism in virulence was examine in the O1 serotype
strain of V. anguillarum NB10Sm. A V. anguillarum NB10Sm icd mutant was created,
characterized for growth in complex media and demonstrated to be as virulent as the wild
type in juvenile rainbow trout. Several additional central metabolism single and double
mutants were created in the following genes cra, gltA, Δicd gltA, sucA, sucC, sdhC,
ΔfrdA, ΔfrdA sdhC, and fumA and characterized with regard to growth in complex media.
Two mutants (ΔsucA and ΔfrdA ΔsdhC) that demonstrated a significantly reduced growth

yield compared to the wild type were further characterized with regard to their growth in
several forms of complex media, expression of virulence genes, and virulence in juvenile
rainbow trout. The data strongly suggest that there is no correlation between a lower
growth yield in vitro and a decrease in virulence in vivo. Even though M93Sm and
NB10Sm are same species, mutations made in the same TCA cycle genes can cause
drastically difference results in regards to growth and virulence.
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PREFACE
This dissertation has been prepared in the Manuscript format according to the
guidelines of the Graduate School of the University of Rhode Island. The first manuscript
“Isocitrate dehydrogenase mutation in Vibrio anguillarum results in virulence attenuation
and immunoprotection in rainbow trout (Oncorhynchus mykiss)” was submitted to BMC
Microbiology July 31st 2017 and is under revision. The second manuscript
“Characterization of the growth and virulence of a Vibrio anguillarum citrate synthase
mutant” and the third manuscript “Characterization of Vibrio anguillarum NB10Sm TCA
cycle mutants” will be submitted for publication to BMC Microbiology. The first
appendix “Draft genome of the marine pathogen Vibrio coralliilyticus RE22” was
published Dec 3rd 2015 in Genome Announcements. The second appendix “Draft
genome sequence of the emerging bivalve pathogen Vibrio tubiashii subsp. europaeus”
was published July 28th 2016 in Genome Announcements.
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Abstract

Background: Vibrio anguillarum is an extracellular bacterial pathogen that is a causative
agent of vibriosis in finfish and crustaceans with mortality rates ranging from 30% to
100%. Mutations in central metabolism (glycolysis and the TCA cycle) of intracellular
pathogens often result in attenuated virulence due to depletion of required metabolic
intermediates; however, it was not known whether mutations in central metabolism
would affect virulence in an extracellular pathogen such as V. anguillarum.
Results: Seven central metabolism mutants were created and characterized with regard to
growth in minimal and complex media, expression of virulence genes, and virulence in
juvenile rainbow trout (Oncorhynchus mykiss). Only the isocitrate dehydrogenase (icd)
mutant was attenuated in virulence against rainbow trout challenged by either
intraperitoneal injection or immersion. Further, the icd mutant was shown to be
immunoprotective against wild type V. anguillarum infection. There was no significant
decrease in the expression of the three hemolysin genes was detected by qRT-PCR.
Additionally, only the icd mutant exhibited a significantly decreased growth yield in
complex media. Growth yield was directly related to the abundance of glutamate. A
strain with a restored wild type icd gene was created and shown to restore growth to a
wild type cell density in complex media and pathogenicity in rainbow trout.
Conclusions: The data strongly suggest that a decreased growth yield, resulting from the
inability to synthesize α-ketoglutarate, caused the attenuation despite normal levels of
expression of virulence genes. Therefore, the ability of an extracellular pathogen to cause
disease is dependent upon the availability of host-supplied nutrients for growth.
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Additionally, a live vaccine strain could be created from an icd deletion strain.
Keywords: Vibrio anguillarum, TCA cycle, vibriosis, isocitrate dehydrogenase,
virulence, hemolysin
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Background
The aquaculture industry now produces half of all fish intended for human
consumption and employs millions of people worldwide [1]. Although the first value sale
of harvested fish has increased by 267% between 2004 and 2014 to over US$160 billion,
infectious diseases, especially those caused by Vibrio spp. including Vibrio anguillarum,
still represent a major impediment to the production of fish [1]. V. anguillarum causes
diseases in crustaceans and bivalves, and is the leading causative agent of vibriosis in
finfish including salmon, rainbow trout, turbot, sea bass, sea bream, cod, eel, and ayu [2].
Infections by this bacterial species have resulted in severe economic losses to aquaculture
industries worldwide [3].
V. anguillarum is an extracellular pathogen that invades its host fish through the
intestine, skin or gills [4, 5]. Systemic infection by V. anguillarum usually causes fish to
die within 1-4 days [6-9]. Chemotactic motility and the metalloprotease EmpA have been
shown to be important virulence factors during the invasion stage while the siderophore
anguibactin, flagellin subunits and lipopolysaccharides were shown to be important for
persistence in the host during the post-invasion stage [2, 10]. Three secreted proteins that
are cytotoxic against epithelial cells and erythrocytes have been characterized in V.
anguillarum: the HlyA homolog Vah1, the phospholipase Plp, and the MARTX toxin
RtxA [7, 9, 11]. Mutations in vah1 and/or plp resulted in slight attenuation against
juvenile Atlantic salmon (Salmo salar); however, rtxA mutants were avirulent [11, 7, 9].
Additionally, a V. anguillarum mutant that lacks H-NS, a global transcriptional regulator
that represses the transcription of vah1, plp, and rtxA, showed attenuation in virulence
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when injected intraperitoneally, suggesting that proper coordination of gene expression is
an important factor during the post-invasion stage [8].
Since the 1980s, several bacterial species that are auxotrophic for aromatic
compounds have been shown to be avirulent [12-16]. More recently, mutants that are
hypothesized to experience growth defects in the nutrient limited environment inside a
phagocyte have been characterized. In Salmonella enterica, an intracellular bacterial
pathogen, some tricarboxylic acid (TCA) cycle mutant strains were avirulent and
immunoprotective for subsequent wild-type S. enterica infection [17-21]. A functional
fructose repressor (Cra) was also required for S. enterica infection [22]. Similar results
have been observed for central metabolism mutants in other intracellular pathogens such
as uropathogenic Escherichia coli (UPEC), Mycobacterium tuberculosis, and the
facultative intracellular fish pathogen Edwardsiella ictaluri [23-27]. These observations
demonstrate that central metabolism is important for pathogenesis by intracellular
pathogens.
Accordingly, we hypothesized that mutations in central metabolism could
interrupt the infection process of V. anguillarum in juvenile rainbow trout (Oncorhynchus
mykiss). In this study, we identified and created six TCA cycle mutant strains plus one
fructose metabolism mutant strain, and tested their virulence against juvenile rainbow
trout using two infection methods, intraperitoneal (IP) injection and immersion. Further,
the expression of each of the three hemolysin genes (vah1, plp, and rtxA) was examined
to determine whether attenuation resulted from decreased virulence factor expression in
these mutants. The growth rates and yield of each mutant strain in complex media were
also determined. We specifically characterized the growth defect of the attenuated icd
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mutant. We also created, tested, and compared a restored wild type icd strain for
virulence and growth to both the wild type and the icd mutant.
Methods
Bacterial strains, plasmids and growth conditions. V. anguillarum strains (Table 1)
were routinely grown in Lysogeny broth containing 2% NaCl (LB20) [28] or Marine
Minimum Median (3M) + 0.15% glucose [29], supplemented with the appropriate
antibiotic, in a shaking water bath at 27°C. E. coli strains (Table 1) were routinely grown
in Lysogeny broth containing 1% NaCl (LB10) supplemented with the appropriate
antibiotic, in a shaking water bath at 37°C. Antibiotics were used at the following
concentrations: streptomycin, 200 g/ml (Sm200); chloramphenicol, 20 g/ml (Cm20) for
E. coli and 5 g/ml (Cm5) for V. anguillarum; kanamycin, 50 g/ml (Km50) for E. coli
and 80 g/ml (Km80) for V. anguillarum.
Identification of genes in V. anguillarum. V. anguillarum M93Sm draft genome
(accession number NOWD00000000) was annotated by the RAST (Rapid Annotation
using Subsystem Technology) service (http://rast.nmpdr.org/rast.cgi) using the default
settings [30]. The following annotated genomes were downloaded from NCBI: V.
anguillarum 775 (accession numbers: NC_015633.1 and NC_015637.1), 96F (accession
number: NZ_AEZA00000000.1), M3 (accession numbers: NC_022223.1, NC_022224.1
and NC_022225.1), NB10 (accession numbers: NZ_LK021130.1, NZ_LK021129.1 and
NZ_LK021128.1), RV22 (accession number: AEZB00000000.1) and 90-11-286
(accession numbers: NZ_CP011460.1 and NZ_CP011461.1)
Insertional mutagenesis. Insertional mutations were made by using a modification of the
procedure described by Milton et al. [31]. Briefly, primers (Table 2) were designed based
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on the target gene sequence of M93Sm. An internal 200-300 bp DNA fragment of the
first third of the target gene was PCR amplified and ligated into the suicide vector
pNQ705-1 (Table 1) after digestion with SacI and XbaI. The ligation mixture was
introduced into E. coli SM10 by electroporation using a BioRad Gene Pulser II (BioRad,
Hercules, CA). Transformants were selected on LB10 Cm20 agar plates. The construction
of the recombinant pNQ705 was confirmed by both PCR amplification and restriction
enzyme analysis. The mobilizable suicide vector was transferred from E. coli SM10 into
V. anguillarum by conjugation [32]. Transconjugants were selected by utilizing the
chloramphenicol resistance gene located on the suicide plasmid. The incorporation of the
recombinant pNQ705 was confirmed by PCR amplification.
Fish infection experiments. Various V. anguillarum strains were tested for virulence
against rainbow trout (O. mykiss) by intraperitoneal (IP) injection or immersion.
Briefly, V. anguillarum cells grown for 19 h at 27°C in LB20 supplemented with the
appropriate antibiotics were harvested by centrifugation (9,000 × g, 5 min, 4°C), washed
twice in NSS, and resuspended in NSS. Aliquots (100 µl) of the V. anguillarum NSS
suspension were used to determine the OD600. The V. anguillarum NSS suspension was
prepared to the desired specific cell density according to the conversion equation as
determined by experimentation (data not shown): Cell density (108 CFU/ml) = 44.905 ×
OD600. The actual cell density of the suspension was confirmed by dilution and viable
plate count. All fish were examined and determined to be disease and injury free prior to
the start of each experiment. For IP injection, fish were anesthetized by tricaine
methanesulfonate (Western Chemical, Ferndale, WA), (100 mg/l for induction and 52.5
mg/l for maintenance). V. anguillarum strains were IP injected into fish that were
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between 15 and 25 cm long in a 100 μl NSS vehicle at a dose of either 2 × 105 or 4 × 105
CFU/fish, or with NSS only as a negative control. For immersion, 10 ml of V.
anguillarum suspended in NSS, or 10 ml of NSS only as a negative control was added to
a bucket filled with 10 L of water supplemented with 1.5% NaCl that was maintained at
18 ± 1ºC. Fish that were between 15 and 25 cm long were added and immersed for 1 h.
For both methods, fish inoculated with different bacterial strains were maintained in
separate 10-gallon (38 L) tanks to prevent possible cross-contamination with constant
water flow (200 ml/min) at 18 ± 1ºC. Death due to vibriosis was determined by the
observation of gross clinical symptoms and confirmed by the recovery and isolation of V.
anguillarum cells resistant to the appropriate antibiotics from the spleen or head kidney
of dead fish. Observations were made for 8-14 days. All fish used in this research project
were obtained from the URI East Farm Aquaculture Center. All fish infection protocols
were approved by the URI IACUC. (IACUC Protocol AN06-08-002).
RNA isolation. Exponential phase cells (~0.5 × 108 CFU/ml) of various V. anguillarum
strains were treated with RNAprotect Bacteria Reagent (QIAGEN), following the
manufacturer’s instructions. Total RNA was isolated using the RNeasy kit and QIAcube
(QIAGEN) following the instructions of the manufacturer. All purified RNA samples
were quantified spectrophotometrically by measuring absorption at 260 nm and 280 nm
using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific) and overall
quality was assessed by gel electrophoresis. Samples were stored at -75ºC for future use.
Real-time quantitative RT-PCR (qRT-PCR). qRT-PCR was used to quantify various
mRNAs using an LightCycler® 480 Real-Time PCR System (Hoffmann-La Roche Inc.)
and the Brilliant II SYBR Green Single-Step QRT-PCR Master Mix (Agilent
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Technologies), with 10 ng of total RNA in 20 µl reaction mixtures. The thermal profile
was 50°C for 30 min, 95°C for 15 min, and then 40 cycles of 95°C for 30 s and 55°C for
30 s. Fluorescence was measured at the end of the 55°C stage of each cycle. Samples
were run in triplicate along with the no-reverse-transcriptase control and the no-template
control. All experiments were repeated at least twice.
Growth experiments. To cultivate bacteria for growth experiments, V. anguillarum cells
grown overnight at 27°C in LB20 supplemented with the appropriate antibiotics were
harvested by centrifugation (9,000 × g, 2 min), washed twice and resuspended in in NSS.
A 200 µl aliquot of the V. anguillarum NSS suspension was transferred into a 96-well
plate with a clear flat bottom and the optical density at 600 nm (OD600) was read by a
VersaMax™

Absorbance

Microplate

Reader

(Molecular

Devices).

The

V.

anguillarum NSS suspension was prepared to an OD600 of 0.420 (~4 × 107 CFU/ml) and
diluted 1:100 into fresh media. Growth was monitored either by measurement of the
OD600 or by serial dilution and plate counts.
Resolving the merodiploid in the icd mutant. V. anguillarum icd mutant cells grown in
LB20 supplemented with appropriate antibiotics for 19 h at 27°C were harvested by
centrifugation (9,000 × g, 2 min), washed three times in NSS, and resuspended in NSS.
Cell suspensions (100 μl) were spread onto Marine Minimum Median (3M) + 0.15%
glucose agar. Well-isolated colonies were picked and subsequently streak purified onto a
new 3M + 0.15% glucose agar. Isolated colonies were then transferred to LB20-Cm5 agar
to screen for chloramphenicol sensitivity. Resolution of the merodiploid was confirmed
by PCR amplification.
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Statistical analysis. A Kaplan-Meier survival analysis with log rank significance test was
performed on the survival curves in the fish infection experiment. Student's T-tests
assuming unequal variances were used for experiments containing two data groups. Oneway ANOVA with Tukey post hoc test was performed for all other experiments. P values
of <0.05 were considered statistically significant.
Results
Identification and mutant construction of TCA cycle genes in V. anguillarum. In
order to identify gene targets for mutagenesis the published genomes of V. anguillarum
strains 775, 96F, M3, NB10, RV22, 90-11-286 and the V. anguillarum M93Sm draft
genome (unpublished data) annotated by RAST were examined and found to have the
following TCA cycle genes/operons: gltA, acnB, icd, sucAB, sucCD, sdhCDAB, frdABCD
fumA, and mdh (Fig. 1 and Table 3). While this set of genes allows for a fully functional
TCA cycle, none of the strains have a fumC gene, which encodes the aerobic fumarate
class II hydratase. All strains also lack the anaerobic fumarate hydratase (fumB) gene.
Additionally, all strains possessed cra, which encodes the repressor of fructose
metabolism in S. enterica [22]. The V. anguillarum M93Sm sequences for the icd, sucA,
sucC, sdhC, fumA, mdh, and cra genes were used to create insertional mutations in V.
anguillarum M93Sm. The seven mutant strains and the one restored strain listed in Table
1 were constructed using the primers listed in Table 2 as described in the Methods.
icd mutant is highly attenuated for virulence against rainbow trout. The virulence of
the seven V. anguillarum metabolism mutants were tested on rainbow trout and compared
to wild type M93Sm in order to determine if mutations in metabolism could affect
pathogenesis. Groups of five fish were infected by IP-injection (as described in the
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Methods) with either the wild type (M93Sm), icd mutant (XM420), sucA mutant
(XM440), sucC mutant (XM450), sdhC mutant (XM460), fumA mutant (XM470), mdh
mutant (XM410) or cra mutant (XM430) in NSS at a dosage of ~2×105 CFU per fish.
Injection with NSS only served as a negative control (Mock). During the 14-day
observation window, 40% of M93Sm infected fish survived. Fish infected with the sucA
mutant, sdhC mutant or icd mutant had a higher survival percentage than M93Sm (50%
for sucA mutant, 80% for sdhC mutant, and 100% for icd mutant); however, only the
difference between the icd mutant and M93Sm was statistically significant (p = 0.037)
(Fig 2A). The experiment was repeated using a two-fold higher dose (~4×105 CFU per
fish) of M93Sm and the three mutant strains (icd mutant, sucA mutant and sdhC mutant)
that exhibited attenuated virulence in the previous experiment. At this dose, only 20% of
M93Sm-infected fish survived. Only the icd mutant-infected fish had a statistically
significant higher survival percentage (100%) compared to M93Sm (p = 0.0153) (Fig
2B). The data indicate the icd mutant is avirulent in these experimental conditions.
Further, we tested the virulence of M93Sm and the icd mutant by another
infection route. Groups of 10 fish were infected by immersion as described in the
Methods with M93Sm or icd mutant in 1.5% salt solution at a dose of ~4×106 CFU/ml, or
just immersed in a 1.5% salt solution without V. anguillarum as a negative control
(Mock). During the 14-day observation window, there was a statistically significant
difference (p = 0.007) between the survival of M93Sm infected fish (30%) and icd
mutant infected fish (90%) (Fig. 3). Taken together, the IP infection data and the
immersion infection data demonstrate that the icd mutant is highly attenuated for
infection in rainbow trout.
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Pre-treatment by immersion with the icd mutant protected rainbow trout from the
subsequent challenge of V. anguillarum M93Sm. Fish previously challenged by
immersion with the icd mutant were subsequently challenged with the wild type M93Sm
strain to test if the icd mutant was immunogenic. Six weeks after the initial infection, a
group of five fish that survived the initial infection with the icd mutant (labeled as
“treated with the icd mutant” in Fig. 4) and a group of five “untreated” fish were infected
via immersion with M93Sm at a dose of ~4×106 CFU/ml and were observed for 14 days.
By day 2 all fish in the untreated group died. All fish in the group treated with the icd
mutant survived the 14-day observation period. The difference between the two
experimental groups was statistically significant (p = 0.008). The results indicate that the
icd mutant is immunogenic and protective against wild type infection when administered
by immersion.
All mutants exhibited either same or higher expression levels of the three hemolysin
genes compared to wild type. Vah1, RtxA, and Plp are the three hemolysins found in
M93Sm and are responsible for the hemolytic/cytolytic activity against fish erythrocytes,
leukocyte and epithelial cells [11, 7, 9] and unpublished data]. We tested the expression
of vah1, rtxA and plp during exponential phase to determine whether mutations in
metabolism could affect the expression of these hemolysin genes. Data indicate that in all
mutants except the icd mutant, expression of vah1 and plp were up regulated by 1.4916.15-fold compared to M93Sm with most of the changes being significant (Fig. 5). In
the icd mutant, expression of plp was up regulated by 1.76-fold while the expression of
vah1 was slightly decreased (to 49% of WT), neither of which was a significant change
from M93Sm (Fig. 5). Plp is the most efficient hemolysin against fish erythrocytes [11].
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TCA cycle mutants with an increased expression of plp also demonstrated an increased
zone of hemolysis on 5% fish blood agar plates (Fig. S2). There was no change in the
zone of hemolysis for the icd mutant. Expression of rtxA in all mutants was not
significantly different from M93Sm (Fig. 5). Taken together, all metabolism mutants
have the same or higher expression levels of hemolysin genes compared to the wild type.
icd mutant exhibited significant lower cell density limit than wild type in two forms
of rich media. Fig. 6 shows the typical growth curves for the wild type V. anguillarum
M93Sm and the seven metabolism mutants in LB20 broth. In these growth conditions,
M93Sm, the icd mutant, and the cra mutant exhibited classic bacterial growth curves
with a lag phase, an exponential phase and a stationary phase. The sucA, sucC, sdhC,
fumA and mdh mutants all exhibited a two-stage growth curve, with each stage consisting
of a lag phase and an exponential phase. The exponential phase in the first growth stage
was named exponential phase I and the exponential phase in the second growth stage was
named exponential phase II. The generation times of the exponential phases of all
mutants were longer than for M93Sm (Table 4). The final cell density (measured by
OD600) of the icd mutant after 23 h was the lowest among all strains. Similarly, after 24 h
of growth in LB20 the final cell density (CFU/ml) of the icd mutant was 47% that of
M93Sm (Table 5) and the difference is significant (p = 0.011). M93Sm and the icd
mutant were grown in NSS supplemented with 200 µg protein/ml of fish gastrointestinal
mucus (NSSM) to better replicate conditions within a host. After 24 h of growth in
NSSM the final cell density of the icd mutant was only ~31% of that for M93Sm (Table
5) and the difference is significant (p = 0.007).
Growth in LB20 supplemented with 118 mM glutamate restores growth of the icd
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mutant to wild type levels. The icd mutant is unable convert isocitrate into αketoglutarate, the immediate precursor of glutamate. Consequently, the icd mutant was
only able to grow in 3M + 0.15% glucose with the addition of glutamate (Fig. 7A).
Glutamate was added to LB20 to determine if the icd mutant final cell density would
increase. Fig. 7B shows the typical growth curves of M93Sm and the icd mutant in LB20
with (solid lines) and without (dashed lines) the addition of 118 mM of glutamate. After
24 h, M93Sm and the icd mutant grew to similar final cell densities when LB20 was
supplemented with 118 mM glutamate. Additionally, Fig. 7C demonstrate that decreasing
the amount of glutamate (from 118 mM to 2.95 mM) added to LB20 decreases the final
cell density of the icd mutant, but not M93Sm, after 24 h of growth. The final cell density
of the icd mutant was not restored to a wild type level when LB20 was supplemented
with glucose, succinate (Fig. S3) or gluconate (Fig. 7C).
Resolving the merodiploid in the icd mutant restores growth and pathogenicity. A
revertant to the wild type icd gene was selected to demonstrate that the icd mutant
(XM420, a merodiploid with an insertion in the icd gene) contained no additional
mutations that could be causing the loss of pathogenicity and decreased cell density.
Initially, attempts were made to complement the icd mutant in trans by cloning icd and
its native promoter into the pSUP203 vector; however, all pSUP203-icd vectors isolated
from E. coli SM10 contained single nucleotide substitutions that resulted in amino acid
changes in icd that inactivated isocitrate dehydrogenase (data not shown). Since the icd
mutant is unable to grow on 3M + glucose, icd mutants that spontaneously resolved the
merodiploid were isolated on 3M + glucose agar plates as described in the Methods. The
reversion rate of the icd mutant to a wild type phenotype grown in LB20 overnight was
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calculated to be 1 out of 1.6 × 1010 cells. Fig. S1 shows the typical growth curves for
M93Sm, the icd mutant and the restored icd strain in LB20 and 3M + 0.15% glucose.
M93Sm and the restored icd strain were able to grow in 3M + 0.15% glucose unlike the
icd mutant (Fig S1A). Additionally, when the strains were grown in LB20 the final cell
density returned to wild type levels when icd was restored (Fig. S1B). To determine if
restoring icd restores pathogenicity, juvenile rainbow trout were challenged via
immersion with M93Sm, the icd mutant and the restored icd strain at a dose of between
4×106 and 8×106 CFU/ml. After day 8, 26% (5/19) of the M93Sm challenged fish, 40%
(6/15) of the restored icd challenged fish and 95% (19/20) of the icd mutant challenged
fish survived (Fig. 8). There was no statistically significant difference between M93Sm
and the restored icd strain (P = 0.50). Again, there was a statistically significant
difference between M93Sm and the icd mutant (p < 0.00004). The results indicate that
when the merodiploid present in the icd mutant is resolved, wild type levels of growth in
3M + 0.15% glucose and LB20 and pathogenicity against juvenile rainbow trout is
returned.
Discussion
The tricarboxylic acid (TCA) cycle is involved in the generation of energy
through the oxidation of acetate. TCA intermediates serve as precursor metabolites for
the synthesis of amino acids and peptidoglycan. The M93Sm genome along with the
published genomes of V. anguillarum strains 775, 96F, M3, NB10, RV22, 90-11-286
were examined for TCA cycle enzymes and the following genes were found: gltA, acnB,
icd, sucAB, sucCD, sdhCDAB, frdABCD fumA, and mdh (Fig. 1 and Table 3).
Additionally, cra, which encodes the repressor of fructose metabolism in S. enterica and
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E. coli and has previously been shown to be essential for S. enterica virulence, is present
in the V. anguillarum genomes [22].
When in a nutrient limited environment, bacteria must be able to synthesize any essential
metabolites that are not freely available in order to grow. Previous studies have shown
that mutations in central metabolism genes result in attenuation of virulence in several
intracellular pathogens including S. enterica, uropathogenic E. coli (UPEC), M.
tuberculosis and E. ictaluri [19, 21, 26, 23-25, 17, 18]. These observations suggest that
central metabolism is necessary for these intracellular pathogens to function inside the
nutrient-limited environment of the phagosome; however, V. anguillarum is not an
intracellular pathogen. While some studies have suggested that V. anguillarum can
survive internally in fish epithelial cells and CHSE cells (derived from pooled embryonic
cells from Oncorhynchus tshawytscha), more recent studies have demonstrated that V.
anguillarum actively evades phagocytosis by fish epithelial cells and cannot survive for
24 h in macrophages [33-36]. In this study, fish were infected with V. anguillarum strains
by either of two methods: intraperitoneal injection or immersion with both methods
resulting in a similar percent survival when fish were challenged with M93Sm (20% for
injection, see Fig 2A and 2B; 0%~30% for immersion, see Fig. 3). Only the icd mutant
had a statistically significant higher level of survival compared to the wild type, 100% for
IP injection (Fig 2A and 2B) and 90% for immersion (Fig. 3). It is not thought that
reversion of the merodiploid to a wild type phenotype caused the other metabolism
mutants to be virulent because Cm resistant colonies were isolated from the organs of
dead fish. IP injection bypasses the need for invasion. No mortalities resulted from IP
injection with the icd mutant indicating that icd is required for V. anguillarum persistence
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and growth in fish tissues. Rainbow trout infected with the icd mutant via immersion and
subsequently challenged with the M93Sm wild type showed 100% survival (Fig. 4)
demonstrating that the icd mutant had immunoprotective effects and elicited an adaptive
immune response. Moreover, as a proof of concept, the data suggest that an icd deletion
mutant could be the basis for a live attenuated vaccine against V. anguillarum infection.
Our observation that a knockout of the icd gene results in attenuation of virulence
raises the question of whether expression of required virulence genes is significantly
reduced in the mutant and, therefore, results in attenuation. We previously identified and
characterized three hemolysin/cytolysin genes and their encoded proteins secreted by V.
anguillarum: plp, vah1 and rtxA [11, 7, 9]. While mutations in plp and vah1 have modest
effects on virulence against fish epithelial cells and fish, a knockout mutation in rtxA is
avirulent in fish [11, 7, 9]. All metabolism mutants exhibited no significant declines in
the expression of three hemolysins (Fig. 5) and most of the mutants exhibited increased
expression. Accordingly, the icd mutant is not attenuated by the lack of hemolysin
production because the decrease in rtxA and vah1 expression was not significant;
however, future studies could examine the expression of other virulence factors. It is
unclear why expression of plp and vah1 is increased in the metabolism mutants. Minato
et al [37] demonstrated the accumulation of acetyl-CoA in Vibrio cholerae central
metabolism mutants resulted in an increased expression of its virulence gene activator
ToxT. It is possible that accumulation or depletion of certain metabolites in V.
anguillarum could increase hemolysin/cytolysin expression. Expression of hlyU, the
positive regulator of the both the vah1 plp gene cluster and the rtxA gene cluster, was
examined and shown to be up-regulated in the sucA and mdh mutants (data not shown)
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[38]. However, the increased expression of hlyU may not be the sole explanation for the
increased expression of plp and vah1 because an increase in expression of rtxA should
have also occurred.
The growth rate and final cell density was determined for all metabolism mutants grown
in LB20 for 24 h. The slowest growing mutant, fumA, was as virulent as the wild type
while the mutant with the lowest final cell density, icd, was attenuated suggesting that
decreased final cell density results in a loss of pathogenicity against rainbow trout (Fig. 2,
Fig. 6, Table 4 and Table 5). When the mutation in icd was resolved, the restored icd
strain demonstrated the wild type phenotype for both growth and pathogenicity (Fig. S1A
and B and Fig. 8). While it is possible that the insertional mutation affected the
expression of the two genes flanking icd (ribosomal large subunit pseudouridine synthase
E (Accession number: WP_017043910.1) and cold shock domain protein CspD
(Accession number: WP_013857087.1)), it is unlikely as neither gene is part of an operon
that includes icd. Since isocitrate dehydrogenase catalyzes the formation of αketoglutarate (the immediate precursor of glutamate) from isocitrate, the icd mutant is
auxotrophic for glutamate (Fig. 7A). Our data demonstrate that the icd mutant stops
growing once exogenous glutamate or its derivatives are exhausted (Fig. 7B and Fig. 7C).
The data also demonstrate the decreased growth yield was not do to a reduction of ATP
production as addition of gluconate or succinate did not restore growth to a wild type cell
density. It is interesting that the only other auxotrophic mutant, sucA, grows to a wild
type cell density in LB20 and is as virulent as the wild type considering it cannot
synthesize succinyl-CoA, a metabolite needed for the synthesis of lysine, methionine and
diaminopimelic acid. Presumably, succinyl-CoA or its derivatives are not limiting in
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LB20 or in fish tissues. Furthermore, this also suggests that the icd mutant is primarily
starved for glutamate and would not need to synthesize succinyl-CoA by metabolizing
glutamate to α-ketoglutarate. We hypothesize that during infection the icd mutant is
unable to obtain enough α-ketoglutarate derivatives to grow to a wild type cell density
and, therefore, cannot reach a cell density necessary for a successful systemic infection.
In support, it has previously been demonstrated that a V. anguillarum M93Sm mugA
mutant that was unable to grow in salmon intestinal mucus was avirulent against Atlantic
salmon [39]. Additionally, when V. anguillarum 775 was cured of its plasmid-encoded
siderophore, the mutant was unable to sequester iron and exhibited decreased virulence.
[40, 41].
M93Sm is an O2α serotype and the presumed infection route is through the
gastrointestinal tract as no necrotic skin lesions have ever been observed with this strain
(unpublished data). The in vitro growth experiment (Table 5) suggests that there are not
enough α-ketoglutarate derivatives in intestinal mucus to support the growth of the icd
mutant to a wild type cell density even though it is the metabolite with the second highest
concentration (3.03 mM) in rainbow trout mucus [42]. It should be noted that for in vitro
growth experiments the concentrations of glutamate and glutamine in the mucus are not
known and the growth conditions represent an ideal environment for growth; V.
anguillarum does not have to evade the fish immune system or compete with commensal
bacteria and it is not expected that the icd mutant will grow to the cell density shown in
the in vitro growth experiments in the fish. As demonstrated by Muroga et al, [43] V.
anguillarum found in the spleen and intestine of moribund fish challenged via immersion
only reached a cell density of 4.0×108 CFU/g and 2.5×107 CFU/g respectively. Altinok et
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al [44] showed a V. anguillarum succinate dehydrogenase mutant was avirulent against
rainbow trout when injected at a dose at 105 CFU. Similar to our results, the authors
showed that the succinate dehydrogenase mutant grew to a cell density slightly lower
than the wild type at 12 h; however, the authors failed to show the growth yield at 24 h.
Further, the authors did not create a complement strain to demonstrate that the loss of
virulence was solely do to mutating sdhB. Most importantly, the ATCC has redesignated
their strain as a Pseudomonas species.
Conclusions
Seven V. anguillarum metabolism mutants were created and examined for
pathogenicity against juvenile rainbow trout, hemolysin/cytolysin expression and growth
in rich media. Of the central metabolism mutants, only the icd mutant showed strong
attenuation in virulence, which did not result from a decrease in virulence factor
expression. In addition, only the icd mutant had a final cell density that was lower than
the wild type, which resulted from the inability to synthesize α-ketoglutarate and
downstream metabolites. Taken together, the data suggest that during infection, if V.
anguillarum is unable to synthesize essential molecules (e.g. α-ketoglutarate/2oxoglutarate) and when those molecules or their derivatives (e.g. glutamate, glutamine)
become limiting in the host, V. anguillarum will be unable to grow to a density necessary
to sustain a systemic infection of the host.
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Table 1. Bacterial strains and plasmids used in this study
Strain or plasmid
V. anguillarum
strains
M93Sm
XM420
ES422
XM440
XM450
XM460
XM470
XM410
XM430
E. coli strains
Sm10
S100
Q420
Q440
Q450
Q460
Q470
Q410
Q430
Plasmid
pNQ705-1
pNQ705-icd
pNQ705-sucA
pNQ705-sucC
pNQ705-sdhC
pNQ705-fumA
pNQ705-mdh
pNQ705-cra

Description

r

Spontaneous Sm mutant of M93 (serotype O2a)
r
r
Sm Cm ; icd insertional mutant
r
Sm ; Restored icd strain
r
r;
Sm Cm sucA insertional mutant
r
r;
Sm Cm sucC insertional mutant
r
r;
Sm Cm sdhC insertional mutant
r
r;
Sm Cm fumA insertional mutant
r
r;
Sm Cm mdh insertional mutant
r
r;
Sm Cm cra insertional mutant
thi thr leu tonA lacY supE recA RP4-2-Tc::Mu::Km
(λ pir)
r
Km ; Sm10 containing plasmid pNQ705-1
r
r
Km Cm ; Sm10 containing plasmid pNQ705-icd
r
r
Km Cm ; Sm10 containing plasmid pNQ705-sucA
r
r
Km Cm ; Sm10 containing plasmid pNQ705-sucC
r
r
Km Cm ; Sm10 containing plasmid pNQ705-sdhC
r
r
Km Cm ; Sm10 containing plasmid pNQ705-fumA
r
r
Km Cm ; Sm10 containing plasmid pNQ705-mdh
r
r
Km Cm ; Sm10 containing plasmid pNQ705-cra
r

Cm ; suicide vector with R6K origin
r
Cm ; For icd insertional mutant
r
Cm ; For sucA insertional mutant
r
Cm ; For sucC insertional mutant
r
Cm ; For sdhC insertional mutant
r
Cm ; For fumA insertional mutant
r
Cm ; For mdh insertional mutant
r
Cm ; For cra insertional mutant
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Reference

[45]
This study
This study
This study
This study
This study
This study
This study
This study
[46]
[47]
This study
This study
This study
This study
This study
This study
This study
[47]
This study
This study
This study
This study
This study
This study
This study

Table 2. Primers used in this study.
Sequence (5' to 3',
Primer
underlined sequences are
designed restriction sites)
GGTGAGCTCTATTCTTTATT
pr31
GCCGATTATC
AAATCTAGAGTAAGTCGCTT
pr32
TAATCGCTTC
AAAGAGCTCGTGATCCAGA
pr50
TGTCGATGCTA
GGTTCTAGAGTTCAGTGTC
pr51
GATAATGTGCA
AAAGAGCTCGGTCGGATTA
pr52
GTACAGCGAAG
GGTTCTAGACTTTTTCAATT
pr53
TCCACGCCGC
AAAGAGCTCATGTTCGTTGC
pr54
GGTCGGAATT
GGTTCTAGATCCAACTCTTC
pr55
AAAGTGGCCC
GGTGAGCTCTCCTTGCACC
pr56
ATATTGATATG
GGGTCTAGAAGGCTTATCA
pr57
TCGAGAAGAGAG
GGTGAGCTCATGCCAGCGT
pr29
TAACATTAAAC
AAATCTAGAGCTGTATGACA
pr30
TCGCACCGGT
AAAGAGCTCGCGGCGTGAG
pr33
ACTAAGGCATC
AAATCTAGACAATGGCAAAG
pr34
CGCAGAAGTA
vah1 F GTTTGGTATGGAACACCGC
RT
TCAAG
vah1 R GGCTCAACCTCTCCTTGTAA
RT
CCAA
CAGACGACCACCAGTAACC
plp F RT
ACTAA
GCAATCATGATGACCCAGC
plp R RT
AACAG
GGAAATTATTCCGCCGACG
Pm111
ATGGA
GCCGATACCGTATCGTTAC
Pm112
CTGAA
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Description
For icd insertional mutant,
forward, SacI
For icd insertional mutant,
reverse, XbaI
For sucA insertional mutant,
forward, SacI
For sucA insertional mutant,
reverse, XbaI
For sucC insertional mutant,
forward, SacI
For sucC insertional mutant,
reverse, XbaI
For sdhC insertional mutant,
forward, SacI
For sdhC insertional mutant,
reverse, XbaI
For fumA insertional mutant,
forward, SacI
For fumA insertional mutant,
reverse, XbaI
For mdh insertional mutant,
forward, SacI
For mdh insertional mutant,
reverse, XbaI
For cra insertional mutant,
forward, SacI
For cra insertional mutant,
reverse, XbaI

Referenc
e
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

For vah1 qRT-PCR, forward This study
For vah1 qRT-PCR, reverse This study
For plp qRT-PCR, forward

[8]

For plp qRT-PCR, reverse

[8]

For rtxA qRT-PCR, forward

[7]

For rtxA qRT-PCR, reverse

[7]

Table 3. Metabolism genes examined in this study
Gene or
Product
operon
gltA
Type II citrate synthase
acnB
Aconitate hydratase B
icd
Isocitrate dehydrogenase
2-oxoglutarate dehydrogenase
sucAB
(E1 component, E2 component)
Succinyl-CoA synthetase
sucCD
(beta subunit, alpha subunit)
Succinate dehydrogenase
(cytochrome b556 subunit, membrane
sdhCDAB
anchor subunit, flavoprotein subunit, ironsulfur protein)
Fumarate reductase
frdABCD
(flavoprotein subunit, iron-sulfur subunit,
anchor subunit, anchor subunit)

Present in sequenced V.
anguillarum strains a
Yes
Yes
Yes
Yes
Yes

Yes

Yes

fumA: Yes;
fumC: not found
fumB
Anaerobic fumarate hydratase (class I)
Not found
mdh
Malate dehydrogenase
Yes
cra
Fructose repressor protein
Yes
a
V. anguillarum strains: M93Sm 775, 96F, M3, NB10, RV22, 90-11-286
fumAC

Aerobic fumarate hydratase (class I, class II)

23

Table 4. Generation times of various V. anguillarum strains grown in LB201
Strain

Exponential Phase I
(Minutes)

Exponential Phase II
(Minutes)

M93Sm

44.00

NA

icd

54.95

NA

sucA

64.32

98.52

sucC

52.42

99.57

sdhC

61.19

101.70

fumA

73.55

89.38

mdh

67.11

115.28

cra

58.59

NA

1

Values calculated from data presented in Figure 6 during exponential growth.
NA: not applicable
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Table 5. Final cell density (CFU/ml) of various V. anguillarum cultures grown for 24 h
Strain

CFU/ml in LB20

M93Sm

3.4×10 (±0.3×10 )

icd

1.6×10 (±0.02×10 )*

9

CFU/ml in NSSM (200 µg/ml)

9

9

9

*Statistically significant difference compared to M93Sm (p <0.05).
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9

9

4.2×10 (±0.7×10 )
9

9

1.3×10 (±0.3×10 )*

Figure Legends
Figure 1. Embden-Meyerhoff-Parnas Pathway, TCA cycle, and metabolism of fructose.
The arrows indicate the physiological directions of the reactions. The gene symbols of the
enzyme for each reaction are listed beside the reaction. Boxed genes indicate the genes
that were mutated in this study (Table 1).
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Figure 2. Percent survival of rainbow trout IP injected with V. anguillarum wild type
5

(M93Sm) and various mutant strains at a dosage of A) 2×10 CFU/fish and B) 4×10

5

CFU/fish. Negative control groups of fish (Mock) were injected with sterile NSS. Five
fish were used for each treatment. (One fish treated with the sucA mutant died, but not
from vibriosis and no V. anguillarum were recovered, so only four fish were counted).
*Statistically significant difference compared to M93Sm (p <0.05).

28

12

29
Mock

*icd

sucA

Time (d)

M93Sm

12

8

B
100%

80%

60%

40%

20%

0%
0
4
8

Mock

*icd

sdhC

sucA

M93Sm

fumA

cra

sucC

mdh

Time (d)

sdhC

Percent Survival

Percent Survival

A
100%
80%

60%

40%
20%
0%
0

4

Figure 3. Percent survival of rainbow trout infected by immersion with V. anguillarum
6

strains M93Sm (wild type) or XM420 (icd) at a dose of 4×10 CFU/ml. A negative
control group of fish (Mock) were immersed in sterile NSS. Ten fish were used for each
treatment. *Statistically significant difference compared to M93Sm (p <0.05).
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Figure 4. Percent survival of immersion vaccinated rainbow trout. Rainbow trout were
sham vaccinated with NSS (labeled as “untreated”) or immersed vaccinated with the icd
mutant (Labeled as “treated with icd”) and challenged with wild type V. anguillarum
6

M93Sm (4×10 CFU/ml). Five fish were used for each treatment. *Statistically
significant difference compared to M93Sm (p <0.05).
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Figure 5. Relative expression of vah1, plp, rtxA determined by qRT-PCR analysis of V.
anguillarum wild-type (M93Sm) and various TCA mutants during logarithmic (Log)phase growth. The data presented are representative of two independent experiments.
Each value is the average for three replicates. Between marked strains and M93Sm: * p <
0.05 and *** p < 0.001. Error bars represent 1 standard deviation.
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Figure 6. Growth curves of various V. anguillarum strains grown in LB20 at 27°C with
shaking (200 rpm). At various time points after inoculation samples were taken for
determination of optical density at 600 nm (OD600). The data are from one representative
experiment.
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Figure 7. Growth of V. anguillarum WT (M93Sm) and the icd mutant under various
conditions. A) Final cell densities (OD600) of V. anguillarum strains after 24 h of growth
in 3M plus 0.15% glucose supplemented with or without 5.9 mM glutamate. B) Growth
curves of V. anguillarum M93Sm (black) and the icd mutant (blue) in LB20 (dashed
lines) or LB20 supplemented with 118 mM glutamate (solid lines). Statistical analysis
was based on data at 24 h. C) Final cell densities (OD600) of V. anguillarum M93Sm and
icd mutant strains grown in LB20 supplemented with decreasing amounts of glutamate.
In each experiment cells grown overnight in LB20 were washed in NSS and used to
o

inoculate the appropriate media. Cultures were incubated at 27 C in a shaking water bath
(200 rpm) and at various time points after inoculation samples were taken for
determination of optical density at 600 nm (OD600). Different letters indicate statistical
significance among groups (p < 0.05). Error bars represent 1 standard deviation.
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Figure 8. Percent survival of rainbow trout immersed with various V. anguillarum strains
6

6

at a dosage of 4×10 to 7×10 CFU/ml. Five fish were used for the uninfected (mock)
group. Fifteen fish were treated with the restored icd strain. Nineteen fish were treated
with M93Sm and twenty fish were treated with the icd mutant. *Statistically significant
difference compared to M93Sm (p < 0.01).
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Supplemental Figure 1. Growth curves of V. anguillarum strains M93Sm (WT), the icd
mutant and the restored icd strain grown in A) 3M + 0.15% glucose and B) LB20. In each
experiment cells grown overnight in LB20 at 27°C were washed in NSS and used to
o

inoculate the appropriate media. Cultures were incubated at 27 C in a shaking water bath
(200 rpm) and at various times after inoculation, samples were taken for determination of
optical density at 600 nm (OD600). Different letters indicate statistical significance among
groups (p < 0.05). Statistical analysis was based on data of stationary phase (>12 h).
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Supplemental Figure 2. Hemolytic activity of various V. anguillarum strains grown on
fish blood agar. Colonies grown overnight on LB20 plates were tooth picked onto LB20
+ 5% trout blood agar plates. The diameter of the zones of hemolysis were measured after
7 h and 23 h of growth at 27°C. Between marked strains and M93Sm: * p < 0.05 and ** p
< 0.01. Error bars represent 1 standard deviation.
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Supplemental Figure 3. Final cell densities (OD600) of V. anguillarum WT (M93Sm) and
the icd mutant after 24 h of growth in LB20 supplemented with or without 118 mM
glucose and 118 mM succinate. Error bars represent 1 standard deviation.
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Abstract
Background: Vibrio anguillarum is an extracellular bacterial pathogen that is a causative
agent of vibriosis in finfish and crustaceans with mortality rates ranging from 30% to
100%. Previously, a V. anguillarum M93Sm isocitrate dehydrogenase mutant
auxotrophic for glutamate was demonstrated to be attenuated in virulence against juvenile
rainbow trout. The inability of the mutant to synthesize essential metabolites (i.e. αketoglutarate and derivatives) was hypothesized to cause the attenuation. In this study, a
citrate synthase mutant was created and characterized to determine if another mutant that
is auxotrophic for glutamate would be attenuated.
Results: A citrate synthase (gltA) deletion mutant was created and characterized with
regard to growth in minimal and complex media, in vitro expression of virulence genes,
and virulence in juvenile rainbow trout (Oncorhynchus mykiss). The ΔgltA mutant
exhibited a decreased final cell density that resulted from the exhaustion of glutamate
from the media. There was no significant decrease in the expression of the three
hemolysin genes when detected by qRT-PCR or mortality during infection experiments.
A ΔgltA mutant capable of growing in minimal media was isolated and shown to have a
spontaneous mutation in the transcriptional activator of 2-methylcitrate synthase (prpR).
This mutation resulted in an increase in expression of 2-methylcitrate synthase (prpC).
This ΔgltA prpR(R66L) mutant exhibited a growth advantage compared to the ΔgltA
mutant after 24 h in spleen extract medium. Further, after growing 120 h in spleen extract
medium, colonies of ΔgltA mutants were shown to be capable of growing in minimal
media. ΔprpC and a ΔgltA ΔprpC mutants were created and characterized with regard to
growth in minimal and complex media and virulence in juvenile rainbow trout. The ΔgltA
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ΔprpC mutant had no growth advantage in spleen extract medium compared to the ΔgltA
mutant in spleen extract medium but unexpectedly, was still as virulent as the wild type
against rainbow trout. The ΔprpC mutant was similar to the wild type in regards to both
growth in minimal and complex media and virulence against rainbow trout.
Conclusions: The data strongly suggests that simple starvation for glutamate will not
directly result in attenuation of virulence. Additionally, spontaneous mutations can occur
that compensate for the original gene deletion if the new mutation can replace or bypass
the lost metabolic reaction and results in a growth advantage.
Keywords: Vibrio anguillarum, Central metabolism, TCA cycle, vibriosis, citrate
synthase, virulence
Background
Vibrio anguillarum is a causative agent of warm water vibriosis in finfish,
crustaceans and bivalves. Morality rates from infection reach between 30% to 100% and
result in severe economic losses to aquaculture industries worldwide [1, 2]. Typically,
systemic infection causes fish to die within 1 to 4 days [3-6].
V. anguillarum is an extracellular pathogen capable of invading its host through
the gills, skin and intestines [7, 8]. Numerous virulence factors that have been shown to
be important during infection include extracellular proteases, hemolytic cytotoxins, iron
acquisition systems (siderophores), lipopolysaccharides, chemotaxis, and flagella [9].
Three secreted hemolytic cytotoxins, exhibiting activity against multiple cell types have
been characterized in V. anguillarum: Vah1 (HlyA homolog, encoded by vah1),
phospholipase Plp (a phosphatidylcholine-specific phospholipase, encoded by plp), and
the MARTX toxin RtxA (encoded by rtxA) [4, 6, 10]. Expression of the cytotoxins is
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under control of the transcriptional activator HlyU and the repressor H-NS [5, 11].
Mutations in vah1 and/or plp resulted in a slight attenuation in virulence against juvenile
Atlantic salmon (Salmo salar); however, rtxA mutants cannot persist in host tissues and
are avirulent against juvenile Atlantic salmon challenged via intraperitoneal injection [4,
6, 10].
Several bacterial species that are auxotrophic for aromatic compounds have been
shown to be avirulent [12-16]. More recently, central metabolism mutants have been
shown to be attenuated in pathogenicity in the intracellular pathogens Salmonella
enterica, uropathogenic Escherichia coli (UPEC), Mycobacterium tuberculosis, and
Edwardsiella ictaluri, [17-27]. The specific gene mutations that cause attenuation in
virulence are hypothesized to reflect the metabolic reactions necessary to grow in the
nutrient limited environment of the phagosome; if the pathogens cannot utilize the
available nutrients they will fail to multiply to the threshold needed to cause disease [18,
26]. Recently, a V. anguillarum M93Sm icd mutant was shown to be highly attenuated
and immunoprotective in juvenile rainbow trout (Oncorhynchus mykiss) [28]. In vitro
growth experiments demonstrated that the icd mutant grew to a lower cell density (~60%)
than the wild type in two forms of rich media, due to limiting amounts of α-ketoglutarate
derivatives (glutamate and glutamine) in the media. In this study, another TCA cycle
mutant auxotrophic for glutamate was constructed by deleting the citrate synthase gene
(gltA). The ΔgltA mutant was characterized for growth, hemolysin expression, and
pathogenicity against juvenile rainbow trout. Additionally, a ΔgltA mutant strain
containing a spontaneous mutation in the transcriptional regulator prpR capable of
growing in 3M + 0.15% glucose (a medium which should be unable to support the
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growth of ΔgltA mutant) was isolated and characterized for growth in multiple forms of
rich media composed of fish extracts that represent different stages of the infection
process. Consequently, a ΔprpC (2-methylcitrate synthase) and a ΔgltA ΔprpC mutant
were created and characterized for growth in multiple forms of media and pathogenicity
against juvenile rainbow trout.
Methods
Bacterial strains, plasmids, and growth conditions. V. anguillarum strains (Table 1)
were routinely grown in Lysogeny broth containing 2% NaCl (LB20) [29], LB20 + 118
mM glutamate, Marine Minimum Median (3M) + 0.15% glucose [30], NSSM (NSS
supplemented with 200µg/ml of fish intestinal mucus) or Spleen extract medium
supplemented with the appropriate antibiotic, in a shaking water bath at 27°C. Spleens,
extracted from previously euthanized rainbow or brook trout, were added to 1 ml of NSS,
placed in an ice-bath and sonicated using Fisher Scientific Sonic Dismembrator Model
500 four times at 10% power for a continuous 10 s. Tubes were then centrifuged (6000 ×
g, 10 min) and the supernatant was collected and centrifuged again (9000 × g, 10 min). 1
ml aliquots of the supernatant were added to a sterile 6-well plate (CytoOne) and
sterilized with ultraviolet light using a Hoefer UV500 (Time = 10 min). An aliquot of the
supernatant was added to LB20 and observed for growth to ensure that the spleen extract
was sterile. E. coli strains (Table 1) were routinely grown in Lysogeny broth containing
1% NaCl (LB10) supplemented with the appropriate antibiotic, in a shaking water bath at
37°C. Antibiotics were used at the following concentrations: streptomycin, 200 g/ml
(Sm200); chloramphenicol, 20 g/ml (Cm20) for E. coli and 5 g/ml (Cm5) for V.
anguillarum.
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Allelic exchange mutagenesis. Deletion mutations were made by using a modification of
the procedure described by Milton et al. [31]. Genes of interested were identified using
the M93Sm genome (Accession Number: NOWD00000000) previously annotated by
RAST [33]. Briefly, primers (Table 2) were designed based on the target gene sequence
of M93Sm. A 250 or 401 bp DNA fragment of the 5’ region and the 3’ region of the
target gene was PCR amplified and ligated using the Gibson assembly method into the
suicide vector pDM4 (Table 1) previously digested with SphI or SacI [32]. The Gibson
assembly mixture was introduced into E. coli SM10 by electroporation using a BioRad
Gene Pulser II (BioRad, Hercules, CA). Transformants were selected on LB10 Cm20 agar
plates. The construction of the recombinant pDM4 was confirmed by PCR amplification.
The mobilizable suicide vector was transferred from E. coli SM10 into V. anguillarum by
conjugation. Single-crossover transconjugants were selected with LB20 Sm200 Cm5
plates, and subsequently, double-crossover transconjugants were selected with LB20
Sm200 plates containing 5% sucrose. The resulting V. anguillarum mutants were checked
for the desired allelic exchange by PCR amplification using primers (Table 2) flanking
the deletion.
Cell

growth

experiments.

To

cultivate

cells

for

growth

experiments,

V.

anguillarum cells grown overnight at 27°C in LB20 supplemented with the appropriate
antibiotics were harvested by centrifugation (9,000 × g, 2 min), washed twice and
resuspended in in NSS. A 200 µl aliquot of the V. anguillarum NSS suspension was
transferred into a 96-well plate with a clear flat bottom and the optical density at 600 nm
(OD600) was read by a VersaMax™ Absorbance Microplate Reader (Molecular Devices).
The V. anguillarum NSS suspension was prepared to an OD600 between 0.400 and 0.500
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(~4 × 107 CFU/ml) and diluted 1:100 into fresh media. Growth was monitored either by
measurement of the OD600 or by serial dilution and plate counts.
RNA isolation. Exponential phase cells (3.9×107 to 7.3×107 CFU/ml) of various V.
anguillarum strains were treated with RNAprotect Bacteria Reagent (QIAGEN)
following the manufacturer’s instructions. Total RNA was isolated using the RNeasy kit
following the instructions of the manufacturer. All purified RNA samples were quantified
spectrophotometrically by measuring absorption at 260 nm and 280 nm using a
NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific) and overall quality
was assessed by gel electrophoresis. Samples were stored at -75ºC for future use.
Real-time quantitative RT-PCR (qRT-PCR). qRT-PCR was used to quantify various
mRNAs using an LightCycler® 480 Real-Time PCR System (Hoffmann-La Roche Inc.)
and the Brilliant II SYBR Green Single-Step QRT-PCR Master Mix (Agilent
Technologies), with 10 ng of total RNA in 20 µl reaction mixtures. The thermal profile
was 50°C for 30 min, 95°C for 15 min, and then 40 cycles of 95°C for 30 s and 55°C for
30 s. Fluorescence was measured at the end of the 55°C stage of each cycle. Samples
were run in triplicate along with the no-reverse-transcriptase control and the no-template
control. All experiments were repeated twice.
Fish infection experiments. Various V. anguillarum strains were tested for virulence
against rainbow trout by immersion infection. Briefly, V. anguillarum cells grown for 19
h at 27°C in LB20 supplemented with the appropriate antibiotics were harvested by
centrifugation (6,000 × g, 10 min, 4°C), washed twice in NSS, and resuspended in NSS.
The V. anguillarum NSS suspension was prepared to the desired specific cell density
according to the conversion equation: Cell density (108 CFU/ml) = 44.905 × OD600. The
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actual cell density of the suspension was confirmed by dilution and viable plate count.
All fish were examined and determined to be disease and injury free prior to the start of
each experiment. For immersion, 10 ml of V. anguillarum suspended in NSS, or 10 ml of
NSS only as a negative control was added to a bucket filled with 10 L of water
supplemented with 1.5% NaCl that was maintained at 18.5 ± 0.5ºC. Fish that were
between 15 cm and 25 cm long were added and immersed for 1 h. For both methods, fish
inoculated with different bacterial strains were maintained in separate 38 L or 191 L
tanks to prevent possible cross-contamination with constant water flow (200 ml/min) at
19 ± 1ºC. Death due to vibriosis was determined by the observation of gross clinical
symptoms and confirmed by the recovery and isolation of V. anguillarum cells resistant
to the appropriate antibiotics from the spleen or head kidney of dead fish. Observations
were made for 7 days. All fish used in this research project were obtained from the
Lafayette Trout Hatchery located in North Kingstown, Rhode Island. All fish infection
protocols were approved by the URI IACUC. (IACUC Protocol AN06-08-002).
Statistical analysis. Student's T-tests assuming unequal variances were used for
statistical analyses for experiments containing two data groups. One-way ANOVA with
repeated measures plus Tukey post hoc test was performed on bacterial growth curves. A
Kaplan-Meier survival analysis with log rank significance test was performed on the
survival percentage in the fish infection experiment. P values of <0.05 were considered
statistically significant.
Results
ΔgltA mutant exhibited significant lower cell density limit than wild type in rich
media and is auxotrophic for glutamate. Fig 1A shows a typical growth curve for the
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wild type (M93Sm) and the ΔgltA mutant composed of a lag phase, exponential growth
phase and stationary phase grown in a rich medium (dashed lines). Like the previously
described icd mutant, the gltA mutant has a lower cell density limit rich media [28]. The
gltA mutant is auxotrophic for glutamate because it cannot run the first half of the
oxidative TCA cycle which is needed to synthesize the immediate precursor molecule for
glutamate production, α-ketoglutarate (Fig 1B). When glutamate (118 mM final
concentration) was added to LB20 (solid lines), the ΔgltA mutant grew to a wild type cell
density (Fig 1A).
ΔgltA mutant exhibited either same or higher expression levels of the three
hemolysin genes compared to wild type. As previously described, M93Sm secretes
three hemolysins, Vah1, RtxA, and Plp that are most strongly expressed during
exponential phase [11]. The expression of vah1, rtxA and plp was tested by qRT-PCR
during exponential phase to determine if the ΔgltA mutant would have altered expression
of these hemolysin genes. While there was no statistically significant increase in
expression (P values ranged from 0.08 to 0.42), the gltA mutant exhibited 1.3-fold greater
rtxA expression, 1.9-fold greater plp expression and 3.7-fold greater vah1 expression
compared to the wild type (Fig. 2).
ΔgltA mutant was as virulent as the wild type against juvenile rainbow trout. Ten
juvenile rainbow trout were challenged via immersion at doses of 3×106 to 4×106
CFU/ml with the wild type (M93Sm) and the ΔgltA mutant. There was no significant
difference in survival between M93Sm (10%) and the ΔgltA mutant (20%) (P = 0.31)
(Table 3); however, it took three days for the ΔgltA mutant to reach 80% mortality
compared to two days for 90% mortality in fish infected with M93Sm. While the data
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strongly suggest that deleting gltA had a very small effect on virulence, the delay in
mortalities raised the possibility that a mutation that compensated for the loss of citrate
synthase was selected in the infected fish.
A mutation in prpR allowed the ΔgltA mutant to grow in 3M + 0.15% glucose. In
order to test for the possibility that a compensatory mutation that would bypass the ΔgltA
mutation could have been selected, the ΔgltA mutant was grown in 3M + 0.15% glucose
for multiple days. An Δicd mutant was also created and was unable to grow in
3M+0.15% glucose (data not shown). The ΔgltA mutant began to grow after 48 h,
reaching wild type levels by 72 h (Fig. 3). A frozen stock was created from the 72 h
culture. A single colony, isolated from the frozen stock, was used for another growth
experiment in 3M + 0.15% glucose. This new strain was able grow in 3M + 0.15%
glucose during a 24 h incubation. When the gltA gene was sequenced from this strain,
there was no change in the sequence from the original ΔgltA mutation; it remained
truncated.
It has previously been described that 2-methylcitrate synthase (PrpC), an enzyme
that combines propionyl-COA and oxaloacetate to synthesize 2-methylcitrate, can act in a
promiscuous manner and synthesize citrate from acetyl-CoA and oxaloacetate [34].
Accordingly, prpB (2-methylisocitrate lyase), prpC, prpR (transcriptional regulator) and
the intergenic regions were sequenced using the primers listed in Table 2. A single
nucleotide mutation was found in prpR that changed amino acid 66 from an arginine to a
leucine. The wild type and the parental ΔgltA mutant did not have this mutation. No
mutations were found in prpB, prpC or the intergenic regions. The spontaneous mutant
was designated as ΔgltA prpR (R66L).
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ΔgltA prpR(R66L) mutant has a higher expression level of prpC compared to wild
type and the ΔgltA mutant. Digianantonio et al [35] demonstrated that increased
expression of prpC enabled an E. coli ΔgltA mutant to grow on minimal media agar.
Accordingly, the expression of prpC was measured by qRT-PCR during exponential
phase to determine if the mutation found in the transcriptional regulator prpR of the
ΔgltA prpR(R66L) mutant would cause an increase in expression of prpC. The ΔgltA
prpR(R66L) mutant exhibited a 12- and 8-fold increase in expression compared to the
wild type (M93Sm) and the ΔgltA mutant, respectively. These increases in prpC
expression were statistically significant (P<0.01) demonstrating that the prpR(R66L)
mutation caused an increase in expression of prpC (Fig. 4).
The ΔgltA prpR(R66L) mutant grew to a higher total cell density in spleen extract
medium compared to the ΔgltA mutant. The final cell densities (CFU/ml) were
determined for the wild type (M93Sm), the ΔgltA mutant and the ΔgltA prpR(R66L)
mutant after 24 h of growth in three forms of rich media: LB20, NSSM and NSS
supplemented with spleen extract (Table 4). In LB20 and NSSM, both the ΔgltA mutant
and the ΔgltA prpR(R66L) mutants grew to a total cell density that was statistically lower
than M93Sm. The difference between the ΔgltA mutant and the ΔgltA prpR(R66L)
mutant was not statistically significant. In the spleen extract medium, M93Sm grew to the
highest cell density (7.7×107 CFU/ml) followed by the ΔgltA prpR(R66L) mutant
(1.5×107 CFU/ml), while the ΔgltA mutant grew to 5.7×107 CFU/ml. The difference
between M93Sm and the ΔgltA prpR(R66L) mutant was not statistically significant. The
data strongly suggest that the ΔgltA prpR(R66L) mutant had a growth advantage in
spleen extract medium compared to the ΔgltA mutant.
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The prpR(R66L) mutation in the ΔgltA mutant can be selected for in spleen extract
medium. The wild type (M93Sm), the ΔgltA mutant and the ΔgltA prpR(R66L) mutant
were grown in spleen extract medium for multiple days (Fig. 5). By 96 h, number of
viable cells in the cultures of both M93Sm and the ΔgltA prpR(R66L) mutant began to
decline. However, the cell density of the ΔgltA mutant increased between 96 h and 120 h.
Colonies were chosen at random from the ΔgltA mutant 120 h agar plate and screened to
ensure that the ΔgltA mutation was still deleted and if the colonies could grow in 3M +
0.15% glucose. All colonies had the truncated version of gltA while 4 out of the 6
colonies grew in 3M + 0.15% glucose with only a 24 h incubation. Although, it was not
screened, the ability to grow 24 h in minimal media (Fig. 5) was presumably from a
mutation in prpR. The data suggest that the prpR(R66L) mutation in the ΔgltA mutant
strain is favored in spleen extract medium.
ΔgltA ΔprpC mutant is unable to grow in 3M + 0.15% glucose and grows to a lower
cell density limit in two forms of rich media. A ΔprpC mutant and a ΔgltA ΔprpC
mutant were created and their growth was examined. After 24 h, the ΔgltA ΔprpC mutant
grew to a lower cell density in LB20 compared to the wild type (M93Sm) (Fig. 6A) and
failed to grow in 3M + 0.15% glucose after 192 h (Fig. 6B). Growth in spleen extract
medium was monitored and after 210 h the ΔgltA ΔprpC mutant failed to grow to the cell
density of M93Sm or the ΔgltA mutant (Fig. 6C). The ΔprpC mutant grew to a wild type
cell density in all forms of media (Fig. 6). The data demonstrate that when prpC is
deleted in the ΔgltA mutant, the bacteria are no longer able to grow in 3M+0.15%
glucose and lose their growth advantage in spleen extract media. However, the loss of
prpC alone had little effect on growth.
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ΔgltA ΔprpC double mutant is as virulent as the wild type against juvenile rainbow
trout. Five to nine juvenile rainbow trout were challenged via immersion at a dose of
4×106 CFU/ml to 6×106 CFU/ml with either the wild type (M93Sm), the ΔprpC mutant,
or the ΔgltA ΔprpC mutant. Fish infected with either M93Sm or the prpC mutant had 0%
survival after 3 and 2 days, respectively (Table 5). While fish infected with the ΔgltA
ΔprpC mutant had 22% survival, there was no significant difference in survival between
M93Sm (0%) and the ΔgltA ΔprpC mutant (P = 0.23). The data suggest that deleting
both gltA and prpC causes only a small attenuation of virulence.
Discussion
Citrate synthase catalyzes the first of eight reactions in the generation of energy
through the oxidation of acetate by the tricarboxylic acid (TCA) cycle. TCA
intermediates also serve as precursor metabolites for the synthesis of amino acids and
peptidoglycan. Specifically, this investigation focused on the inability of the ΔgltA
mutant to produce the TCA cycle intermediate and immediate precursor to glutamate
synthesis, α-ketoglutarate. Previously, a V. anguillarum icd mutant was shown to be both
highly attenuated in virulence and immunoprotective in juvenile rainbow trout [28]. The
loss of pathogenicity was hypothesized to have resulted from the inability to synthesize
glutamate; the cells would stop replicating and be prevented from reaching the threshold
needed to cause systemic infection after they exhausted glutamate from their host.
Aromatic compound auxotroph mutants have been demonstrated to be highly attenuated
since the 1980s [12-16]. More recent studies have demonstrated that intracellular
pathogens containing TCA cycle mutations are attenuated for virulence if the specific
mutations prevent growth using the available nutrients in the nutrient-poor phagosome
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[17-27]. Since V. anguillarum is not an intracellular pathogen and cannot survive in
macrophages, it would not be subject to this type of nutrient limitation [36]. Additionally,
the initial infection site V. anguillarum M93Sm, an O2α serotype, is presumably the
intestines (external necrotic lesions have never been observed in fish exposed to this
strain, unpublished observations) where it grows in the glutamate rich intestinal mucus
[7, 8, 37]. Therefore, the previously described link between glutamate auxotrophy and
attenuation in virulence in M93Sm warranted further investigation [28].
A ΔgltA strain was created and showed the same growth phenotype as the
previously described icd mutant (Fig. 1) [28]. Unlike the icd mutant, the gltA mutant was
as virulent as the wild type against juvenile rainbow trout. However, death from systemic
infection was delayed by about 1 day (Table 3) suggesting that a compensatory mutation
that could bypass the citrate synthase deletion was being selected for in the ΔgltA mutant.
Indeed, a ΔgltA strain capable of growth in 3M + 0.15% glucose media (a medium in
which it should fail to grow) was isolated (Fig. 3). When this ΔgltA strain was sequenced
a spontaneous mutation was found in prpR, the transcriptional activator of 2methylcitrate synthase (prpC), that changed arginine 66 to a leucine (this strain was
named ΔgltA prpR(R66L)). The normal enzymatic function of PrpC is to synthesize 2methylcitrate from propionyl-CoA and oxaloacetate; however, it has been demonstrated
that PrpC can act promiscuously, substituting acetyl-CoA for propionyl-CoA to
synthesize citrate [34]. The ability of the ΔgltA prpR(R66L)) mutant to grow in 3M +
0.15% glucose media resulted from an increase in expression of prpC (Fig. 4). The
increase in expression of prpC enabled the cells to bypass the gltA deletion, an
observation previously described in an E. coli ΔgltA strain by Digianantonio et al [35].
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The hypothesized route of infection for V. anguillarum M93Sm is through the
anus of the fish where it damages the lining of gastrointestinal tract to enter the
circulatory system where it accumulates in the spleen [7, 8]. Accordingly, the in vitro
growth of the ΔgltA prpR(R66L) mutant was characterized in NSSM and spleen extract
medium to represent the environment of early and mid-stage infections respectively
(LB20 served as a control). The growth advantage of the ΔgltA prpR(R66L) mutant in
spleen extract medium coupled with the isolation of spontaneous prpR mutants in the
ΔgltA mutant after extended growth in spleen extract medium suggest that during
infection with the ΔgltA mutant, mutations in prpR are selected for in the fish spleen
allowing the ΔgltA mutant to cause systemic infection. To test this idea, a ΔgltA ΔprpC
mutant was created and was shown to be unable to grow in minimal media and had no
growth advantage in spleen extract. Surprisingly there was no statistically significant
difference in survival in fish challenged with the wild type and the ΔgltA ΔprpC mutant
indicating that glutamate auxotrophy in and of itself may not necessarily result in
attenuation.
The data presented here suggest that our previously proposed hypothesis that
simple starvation for glutamate results in attenuation of virulence must be modified.
While the small decrease in mortality during infection of the ΔgltA ΔprpC mutant
suggests glutamate auxotrophy may contribute to attenuation, it may not be the single
cause of attenuation in virulence of the icd mutant. The oxidative branch of the TCA
cycle is at the intersection of three regulatory molecules: acetyl-CoA, citrate and αketoglutarate. Citrate accumulation has been shown to be detrimental to the growth rate
and growth yield of E. coli with spontaneous citrate synthase mutants outgrowing icd or
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aconitase (acnA and acnB) double mutants during in vitro growth experiments in
complex media [38, 39]. Additionally, in Staphylococcus aureus, citrate has been shown
allosterically activate CcpE, a regulator of metabolism and virulence factors [40]. An E.
coli icd mutant was shown to have increased expression of the glyoxylate shunt causing
lower acetyl-CoA production [41]. During acetogenesis, phosphotransacetylase converts
acetyl-CoA into acetyl-P, a global regulator that is used to phosphorylate two-component
signal transduction pathways [42]. Acetyl-P has been shown to induce virulence factor
expression in V. cholerae, S. enterica and E. coli [43-46]. Further, acetyl-CoA
accumulation alone, without being converting to acetyl-P, was shown to cause increased
expression of the V. cholerae virulence gene activator ToxT [47]. Lastly, α-ketoglutarate
has been shown to be a master regulator that coordinates nitrogen and carbon metabolism
by inhibiting the production of cyclic AMP and has been shown to regulate virulence
factors in UPEC [48-50]. Mutations in gltA or icd in V. anguillarum would result in
altered intracellular levels of acetyl-CoA, citrate and α-ketoglutarate. The phenotype of
the icd mutant (low intracellular levels of acetyl-CoA and high intracellular levels of
citrate) could be causing the attenuation of virulence against juvenile rainbow trout
because the cells can no longer sense their metabolic environment and consequently
cannot properly coordinate the expression of appropriate virulence factors in vivo.
While expression levels of the three hemolysins in the icd and ΔgltA mutants have
been examined and shown to be the same or higher compared to their expression wild
type M93Sm cells in vitro, (Fig. 4) expression of other virulence factors important for
systemic infection and persistence (the chemotaxic system, protease production,
lipopolysaccharides production, iron acquisition, and flagella synthesis) have not been
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examined and could be effected by the intracellular concentrations of acetyl-CoA, citrate,
or α-ketoglutarate [28]. Further studies examining the entire transcriptome may reveal
whether other potential virulence factors are affected by mutations in icd or gltA in V.
anguillarum.
Conclusion
A V. anguillarum ΔgltA strain was created and was demonstrated to be similar to
the previously described icd mutant; both strains demonstrated a decreased final cell
density in multiple forms of rich media and had expression of hemolysin genes that was
similar to the wild type. Unlike the icd mutant, the ΔgltA mutant was as virulent as the
wild type in juvenile rainbow trout. Spontaneous mutations arose in prpR that caused an
increase in expression of the promiscuous enzyme prpC allowing the ΔgltA mutant to
bypass the gltA deletion and grow in minimal media and have a growth advantage in
spleen extract media. A ΔgltA ΔprpC mutant was created and was demonstrated to be
unable to grow in minimal media and no longer have a growth advantage in spleen
extract media. However, the ΔgltA ΔprpC mutant exhibited only a slight attenuation in
virulence compared to the wild type against rainbow trout further suggesting that simple
starvation for a required nutrient (i.e. glutamate) will not directly result in attenuation of
virulence as previously proposed.
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Table 1 Bacterial strains and plasmids used in this study
Strain or plasmid

Description

Reference

M93Sm

Spontaneous Smr mutant of M93 (serotype O2a)

[51]

ES496

Smr; gltA deletion mutant

This study

ES3-2

Smr; gltA deletion mutant, spontaneous mutation in prpR
(R66L)

This study

ES6600

Smr; prpC deletion mutant

This study

ES496.6600

Smr; gltA prpC double mutant

This study

Sm10

thi thr leu tonA lacY supE recA RP4-2-Tc::Mu::Km (λ pir)

[52]

Q496

Kmr Cmr; Sm10 containing plasmid pDM4-gltA5’-gltA3’

This study

Q6600

Kmr Cmr; Sm10 containing plasmid pDM4-prpC5’-prpC3’

This study

pDM4

Cmr Kmr SacBCr; suicide vector

[30]

pDM4-gltA5’-gltA3’

Cmr SacBCr; For gltA deletion mutant

This study

V. anguillarum
strains

E. coli strains

Plasmid

pDM4-prpC5’-prpC3 Cmr SacBCr; For prpC deletion mutant
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This study

Table 2. Primers used in this study
Primer

Sequence (5'to3', lowercase sequences are
designed to be homologous to flanking
Description1
sequences)

PmG-01

caggttacccgcatgAGCTGCCGATTATGGATGG
For gltA GA 5' region, forward This study
G

PmG-02

ggaatgttaAAGTGAATCATGGTAGAACGCGG For gltA GA 5' region, reverse This study

PmG-03

gattcacttTAACATTCCTGAGTATGTGGTCAGA
For gltA GA 3' region, forward This study
GC

PmG-04

ctagatagatcttgcatgGGCCAGTATAAAGTTGAC
For gltA GA 3' region, reverse This study
GAGGTC

PmG-23

aatcccgggagagctAACGCACCACTGGGCGGC

For prpC GA 5' region,
forward

This study

PmG-24

tgaccaacGCCGGTGCGCATTACGTCC

For prpC GA 5' region,
reverse

This study

PmG-25

gcaccggcGTTGGTCAAAAGCGTTATCTGAAG For prpC GA 3' region,
C
forward

This study

PmG-26

cgggtaacctgagctTTAACGCTGCTCTATTGGTA For prpC GA 3' region,
TCCAC
reverse

This study

PmG-27

GCTCGATAGCATGCAAACCCGT

For prpB sequencing, forward This study

PmG-28

CCGACAATCTGCAGCGGATCAT

For prpB sequencing, reverse This study

Reference

PmG-29C CTGCTCTATTGCCGTGCGAA

For prpC checking, forward

This study

PmG-30C CGAGATCGCGCTTACGCTCA

For prpC checking, reverse

This study

Pm112s

AGCCCGATATCGCGCAGTTAAATG

For gltA checking, forward

This study

Pm117

TTCTTCTGGTGCTAACCCGTTTG

For gltA sequencing

This study

Pm118

GCTCTCGGAGAATGGTTAGCGA

For gltA checking, reverse

This study

vah1F RT GTTTGGTATGGAACACCGCTCAAG

For vah1 qRT-PCR, forward

[28]

vah1R RT GGCTCAACCTCTCCTTGTAACCAA

For vah1 qRT-PCR, reverse

[28]

plp F RT

CAGACGACCACCAGTAACCACTAA

For plp qRT-PCR, forward

[5]

plp R RT

GCAATCATGATGACCCAGCAACAG

For plp qRT-PCR, reverse

[5]

Pm111

GGAAATTATTCCGCCGACGATGGA

For rtxA qRT-PCR, forward

[4]

Pm112

GCCGATACCGTATCGTTACCTGAA

For rtxA qRT-PCR, reverse

[4]

Pm132

TTATGTACTGTCGGAAAAACTGGG

For prpC qRT-PCR, forward

This study

Pm133

TGGTCAAGTTCACTTTGATTAGGT

For prpC qRT-PCR, reverse

This study

1

GA; Gibson Assembly

72

Table 3 Virulence of V. anguillarum strains in juvenile rainbow trout
Strain

Dosage (CFU/ml)

M93Sm

4×10

ΔgltA

3-4×10

6
6

Control (NSS)
1
2

2

Total Mortality

No. of days until
death (No. of fish /
total)

90%

1 (3/10) 2 (9/10)

80%

1 (1/10) 2 (6/10) 3
(8/10)

0%

NA

Sum of two treatments, five fish per treatment
ΔgltA dosage: first treatment (3 ×106), second treatment (4 ×106)
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1

Table 4 Final CFU/ml (±S. D) of various V. anguillarum cultures grown for 24 h1

Strain

CFU/ml in LB20

CFU/ml in NSSM (200
µg/ml)

CFU/ml in spleen
extract (100 µg/ml)

M93Sm

3.4 (±0.3) ×109 [1.00]

4.2 (±1.0) ×109 [1.00]

7.7 (±2.1) ×107 [1.00]

ΔgltA

1.6 (±0.1) ×109 [0.47]**

1.2 (±0.2) ×109 [0.29]*

1.5 (±0.05) ×107 [0.19]*

ΔgltA
prpR(R66L)

1.5 (±0.09) ×109
[0.45]**

1.5 (±0.2) ×109 [0.36]*

5.7 (±0.4) ×107 (0.74)

S.D = standard deviation
1

Values in brackets represent growth percentage compared to wild type.

** statistically significant to wild type (P < 0.01), * statistically significant to wild type (P < 0.05)
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Table 5 Virulence of V. anguillarum strains in juvenile rainbow trout

Strain

Dosage (CFU/ml)

Total Mortality

No. of days until
death (No. of fish /
total)

M93Sm

5×106

100%

1 (6/9) 2 (8/9) 3 (9/9)

ΔprpC

6×106

100%

1 (2/5) 2 (5/5)

ΔgltA ΔprpC

4×106

78%

1 (4/9) 2 (6/9) 3 (7/9)

0%

3 (1/5)*

NSS
*Death was not caused by vibriosis
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Figure 1. Growth of V. anguillarum WT (M93Sm) and the gltA mutant under various
conditions. A) Growth curves of V. anguillarum M93Sm (black) and the gltA mutant
(blue) in LB20 (dashed lines) or LB20 supplemented with 118 mM glutamate (solid
lines). B) Final cell densities (OD600) of V. anguillarum strains after 24 h of growth in 3M
plus 0.15% glucose supplemented with or without 5.9 mM glutamate. In each experiment
cells grown overnight in LB20 were washed twice in NSS, calibrated to an OD600
between 0.4 and 0.5 and used to inoculate the appropriate media at a 1:100 dilution.
o

Cultures were incubated at 27 C in a shaking water bath (200 rpm) and at various time
points after inoculation samples were taken for determination of optical density at 600
nm (OD600). The data are the average of two independent experiments. Different letters
indicate statistical significance among groups (P < 0.05). Statistical analysis was based
on data at 24 h. Between marked strains and M93Sm: ** P < 0.01. Error bars represent 1
standard deviation.
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25

Figure 2. Expression of vah1, rtxA, and plp determined by qRT-PCR analysis of V.
anguillarum wild-type (M93Sm) and the gltA mutant during logarithmic (Log)-phase
growth. The data presented are the averages of two independent experiments. Each value
is the average for six replicates. Error bars represent 1 standard deviation.
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vahI
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M93Sm

ΔgltA

79

plp

Figure 3. Growth curves of various V. anguillarum strains grown in 3M + 0.15% glucose
at 27°C with shaking (200 rpm). At various time points after inoculation samples were
taken for determination of optical density at 600 nm (OD600). In each experiment cells
grown overnight in LB20 were washed twice in NSS, calibrated to an OD600 between 0.4
and 0.5 and used to inoculate the appropriate media at a 1:100 dilution. Cultures were
incubated at 27oC in a shaking water bath (200 rpm) and at various time points after
inoculation samples were taken for determination of optical density at 600 nm (OD600).
The data are the average of two independent experiments. Error bars represent 1 standard
deviation.
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ΔgltA

ΔgltA prpR (R66L)
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24
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Figure 4. Expression of prpC determined by qRT-PCR analysis of V. anguillarum wildtype (M93Sm), the gltA mutant and the gltA mutant with the spontaneous mutation in
prpR(R66L) during logarithmic (Log)-phase growth. The data presented are the averages
of two independent experiments. Each value is the average of six replicates. Between
marked strains and M93Sm: ** P < 0.01. Error bars represent 1 standard deviation.
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M93Sm

Figure 5. Growth curves of various V. anguillarum strains grown in in NSS + spleen
extract (100µg/ml) at 27°C with shaking (200 rpm). The data are a representative of two
independent experiments. At various time points after inoculation samples were taken for
determination CFU/ml by serial dilution and spot plating. In each experiment cells grown
overnight in LB20 were washed twice in NSS, calibrated to an OD600 between 0.4 and 0.5
and used to inoculate the appropriate media at a 1:100 dilution. ΔgltA colonies were
picked from the 120 h plate and used to inoculate 3M + 0.15% glucose. In addition,
colony PCR using primers flanking gltA was performed to ensure gltA was still deleted.
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ΔgltA prpR(R66L)

CFU/ml

1.E+08

1.E+07

1.E+06
24

48

72
96
Time (h)

85

120

144

Figure 6. Growth curves of various V. anguillarum strains grown in in various conditions
at 27°C with shaking (200 rpm). A) Final cell densities (OD600) of V. anguillarum strains
after 24 h of growth in LB20. B) Growth curves of various V. anguillarum strains grown
in 3M + 0.15% glucose at 27°C with shaking (200 rpm). C) Growth curves of various V.
anguillarum strains grown in spleen extract medium at 27°C with shaking (200 rpm).
ΔgltA colonies were picked from the 120 h plate, screened to ensure gltA was still deleted
by colony PCR using primers flanking gltA and were used to inoculate 3M + 0.15%
glucose. At various time points after inoculation samples were taken for determination of
CFU/ml by serial dilution and spot plating or for determination of optical density at 600
nm (OD600). In each experiment cells grown overnight in LB20 were washed twice in
NSS, calibrated to an OD600 between 0.4 and 0.5 and used to inoculate the appropriate
media at a 1:100 dilution. The data for A and B are the average of two independent
experiments. Different letters indicate statistical significance among groups (P < 0.05).
Statistical analysis was based on data at 24 h. Error bars represent 1 standard deviation.
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Abstract
Background: There are twenty-three serotypes of the marine pathogen Vibrio
anguillarum¸ three of which are responsible for causing warm water vibriosis, a fatal
hemorrhagic septicemic disease of fish. A previous study demonstrated that a V.
anguillarum M93Sm (O2a serotype) icd mutant was attenuated in virulence; however, it
is not known if mutating this gene in the O1 serotype V. anguillarum NB10Sm will result
in the same phenotype.
Results: A V. anguillarum NB10Sm icd mutant was created, characterized for growth in
complex media and demonstrated to be as virulent as the wild type. Several additional
central metabolism single and double mutants were created in the following genes cra,
gltA, Δicd gltA, sucA, sucC, sdhC, ΔfrdA, ΔfrdA sdhC, and fumA and characterized with
regard to growth in complex media. Two mutants (ΔsucA and ΔfrdA ΔsdhC) that
demonstrated a significantly reduced growth yield compared to the wild type were further
characterized with regard to their growth is several forms of complex media, expression
of virulence genes, and virulence in juvenile rainbow trout (Oncorhynchus mykiss).
Conclusions: The data strongly suggest that there is no correlation between a lower
growth yield in vitro and a decrease in virulence in vivo. Even though M93Sm and
NB10Sm are same species, mutations made in the same TCA cycle genes can cause
drastically difference results in regards to growth and virulence.
Keywords: Vibrio anguillarum, TCA cycle, vibriosis, virulence, hemolysin, protease
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Background
Vibrio anguillarum is a causative agent of warm water vibriosis, which causes a
fatal hemorrhagic septicemic disease of fish, as well as morbidity and mortality in
crustaceans and bivalves [1-3]. Mortality rates from vibriosis range between 30 to 100%
and contribute to significant economic losses to the aquaculture industry worldwide [1,
3]. Typically, the initial site of infection is the skin, gills or intestines and in vivo studies
have demonstrated that death from system infection usually occurs 1-4 days post
infection [4-9]. Numerous virulence factors that have been shown to be important during
infection include extracellular proteases, hemolytic cytotoxins, iron acquisition systems
(siderophores), lipopolysaccharides, chemotaxis, and flagella [10].
Previously, a V. anguillarum M93Sm icd mutant was shown to be highly
attenuated against juvenile rainbow trout and immunoprotective [11]. Auxotrophic or
TCA cycle mutants attenuated in virulence have been created in several intracellular
bacteria species [12-27]. The attenuation of the V. anguillarum M93Sm mutant was
hypothesized to have resulted from the mutant being unable to grow to a final wild type
cell density. The decreased growth yield resulted from the cells being auxotrophic and
starved for glutamate [11]. If this same growth limitation were to occur during an
infection, the cells would not be able to surpass threshold needed to cause disease.
Interestingly, unlike the previously reported attenuated auxotrophic or TCA cycle
mutants, V. anguillarum is not an intracellular pathogen and would not be experience the
nutrient limitations of the phagosome [28]. Accordingly, glutamate auxotrophy may not
be the single cause of the attenuation of the icd mutant as a later study demonstrated that
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another mutant auxotrophic for glutamate (ΔgltA) was as virulent as the wild type
[Spinard, EJ et al, in preparation, chapter 2 of this manuscript].
There are twenty-three serotypes of V. anguillarum (O1-O23) that have been
differentiated by O-serotyping; only three serotypes (O1-O3) are important pathogens in
fish [29, 30]. M93Sm is a spontaneous streptomycin resistant mutant selected from an
O2a serotype strain originally isolated from a diseased ayu (Plecoglossus altivelis) from
Lake Biwa in Japan [31]. Even though the M93Sm icd mutant stimulated an adaptive
immune response that protected the fish from a subsequent M93Sm wild type challenge,
it may be necessary to create a multivalent vaccine in order to promote full
immunoprotection against multiple serotypes of V. anguillarum. In the late 1980s, salmon
reared in New Brunswick vaccinated with bacterins composed of V. anguillarum serotype
O1 and V. ordalii later died from vibriosis caused by V. anguillarum O2 serotypes;
addition of an O2 bacterin reduced death from V. anguillarum O2 serotype induced
vibriosis [32]. Accordingly, this study focused on creating and characterizing the growth
and virulence of central metabolism mutants in V. anguillarum NB10Sm (spontaneous
streptomycin resistant O1 serotype strain originally isolated from a rainbow trout near the
city of Boden, Sweden) with the goal of creating a live attenuated O1 strain [33].
Methods
Bacterial strains, plasmids, and growth conditions. V. anguillarum strains (Table 1)
were routinely grown in Lysogeny broth containing 2% NaCl (LB20) [34], LB20
containing various additional supplements, Marine Minimum Median (3M) + 0.15%
glucose [35], NSS supplemented with fish gastrointestinal mucus (NSSM), NSS
supplemented with fish skin mucus (NSSSkM) or NSS Spleen extract medium
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supplemented with the appropriate antibiotic, in a shaking water bath at 27°C. E. coli
strains (Table 1) were routinely grown in Lysogeny broth containing 1% NaCl (LB10)
supplemented with the appropriate antibiotic, in a shaking water bath at 37°C. Antibiotics
were used at the following concentrations: streptomycin, 200 g/ml (Sm200);
chloramphenicol, 20 g/ml (Cm20) for E. coli and 5 g/ml (Cm5) for V. anguillarum;
40g/ml (Km40) kanamycin for liquid media or 80g/ml (Km80) kanamycin for solid
media for V. anguillarum and E. coli.
Insertional mutagenesis. Insertional mutations in the target genes: icd, sucA, sucC,
sdhC, fumA and cra were created by using previously constructed suicide vectors [11].
Additional insertional mutations were made by using a modification of the procedure
described by Milton et al. [36]. Briefly, primers (Table 2) were designed based on the
target gene sequence of NB10. A 200-300 bp DNA fragment of the target gene was PCR
amplified and ligated into the suicide vector pNQ705-1 (Table 1) after digestion with
SacI and XbaI. The ligation mixture was introduced into E. coli SM10 by electroporation
using a BioRad Gene Pulser II (BioRad, Hercules, CA). Transformants were selected on
LB10 Cm20 agar plates. The construction of the recombinant pNQ705 was confirmed by
PCR amplification. The mobilizable suicide vector was transferred from E. coli SM10
into V. anguillarum by conjugation [37]. Transconjugants were selected by utilizing the
chloramphenicol resistance gene located on the suicide plasmid. The incorporation of the
recombinant pNQ705 was confirmed by PCR amplification.
Allelic exchange mutagenesis. Deletion mutations were made by using a modification of
the procedure described by Milton et al. [36]. Suicide vectors were constructed via
restriction enzyme digestion/ligation (frdA, sucA, icd, CUO) or Gibson Assembly (sdhC).
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Briefly, primers (Table 2) were designed based on the target gene sequence of NB10
(Accession numbers: NZ_LK021130.1, NZ_LK021129.1 and NZ_LK021128.1). For
restriction enzyme digestion and ligation, a DNA fragment of the 5’ region of the target
gene varying in size from 297 to 425 bp was PCR amplified and ligated into the suicide
vector pDM4 (Table 1) after digestion with SacI and XbaI. Subsequently a section of the
3’ region of the target gene varying in size from 273 to 484 bp was PCR amplified and
ligated into the suicide vector pDM4 containing the previously added 5’ region after
digestion with XhoI and NheI. Finally, the kanamycin resistance cassette was amplified
and ligated into the previously constructed suicide vector after digestions with XbaI and
XhoI. For the Gibson Assembly method [38], primers (Table 2) were designed based on
the target gene sequence of NB10. A 100 bp DNA fragment of the 5’ region and the 3’
region of the target gene was PCR amplified and ligated using the Gibson assembly
method into the suicide vector pDM4 (Table 1) previously digested with SacI. The
ligation or the Gibson Assembly mixture was introduced into E. coli SM10 by
electroporation using a BioRad Gene Pulser II (BioRad, Hercules, CA). Transformants
were selected on LB10 Cm20 agar plates. The construction of the recombinant pDM4 was
confirmed by PCR amplification. The mobilizable suicide vector was transferred from E.
coli SM10 into V. anguillarum by conjugation. Single-crossover transconjugants were
selected with LB20 Sm200 Cm5 Km80 plates, and subsequently, double-crossover
transconjugants were selected with LB20 Sm200 Km80 plates containing 5% sucrose. The
resulting V. anguillarum mutants were checked for the desired allelic exchange by PCR
amplification using primers (Table 2) flanking the deletion.
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Cell growth experiments. V. anguillarum cells grown overnight at 27°C in LB20
supplemented with the appropriate antibiotics were harvested by centrifugation (9,000
× g, 2 min), washed twice and resuspended in in NSS. A 200 µl aliquot of the V.
anguillarum NSS suspension was transferred into a 96-well plate with a clear flat bottom
and the optical density at 600 nm (OD600) was read by a VersaMax™ Absorbance
Microplate Reader (Molecular Devices). The V. anguillarum NSS suspension was
prepared to an OD600 between 0.300 and 0.350 (~1.5 × 109 CFU/ml) and diluted 1:100
into fresh media. Growth was monitored either by measurement of the OD600 or by serial
dilution and plate counts.
Fish infection experiments. Various V. anguillarum strains were tested for virulence
against rainbow trout by immersion infection. Briefly, V. anguillarum cells grown for 20
h at 27°C in LB20 supplemented with the appropriate antibiotics were harvested by
centrifugation (6,000 × g, 10 min, 4°C), washed twice in NSS, and resuspended in NSS.
The V. anguillarum NSS suspension was prepared to the desired specific cell density
according to the conversion equation derived from Supplementary Figure 1: Cell density
= (5 × 109 × OD600) – 4 × 107. The actual cell density of the suspension was confirmed by
dilution and viable plate count. All fish were examined and determined to be disease and
injury free prior to the start of each experiment. For immersion, 10 ml of V. anguillarum
suspended in NSS, or 10 ml of NSS only as a negative control was added to a bucket
filled with 10 L of water supplemented with 1.5% NaCl that was maintained at 19.5 ±
0.5ºC. Fish that were between 15 cm and 25 cm long were added and immersed for 1 h.
For both methods, fish inoculated with different bacterial strains were maintained in
separate 191 L tanks to prevent possible cross-contamination with constant water flow
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(200 ml/min) at 19 ± 1ºC. Death due to vibriosis was determined by the observation of
gross clinical symptoms and confirmed by the recovery and isolation of V.
anguillarum cells resistant to the appropriate antibiotics from the spleen or head kidney
of dead fish. Observations were made for 7 days. All fish used in this research project
were obtained from the Lafayette Trout Hatchery located in North Kingstown, Rhode
Island. All fish infection protocols were approved by the URI Institutional Animal Care
and Use Committee (IACUC) (IACUC Protocol AN06-08-002).
RNA isolation. Exponential phase cells (~3 × 108 CFU/ml) or stationary phase cells (1.0
× 109 to 7.8 × 109 CFU/ml) of various V. anguillarum strains were treated with
RNAprotect Bacteria Reagent (QIAGEN), following the manufacturer’s instructions.
Total RNA was isolated using the RNeasy kit following the instructions of the
manufacturer. All purified RNA samples were quantified spectrophotometrically by
measuring absorption at 260 nm and 280 nm using a NanoDrop ND-1000
spectrophotometer (Thermo Fisher Scientific) and overall quality was assessed by gel
electrophoresis. Samples were stored at -75ºC for future use.
Real-time quantitative RT-PCR (qRT-PCR). qRT-PCR was used to quantify various
mRNAs using an LightCycler® 480 Real-Time PCR System (Hoffmann-La Roche Inc.)
and the Brilliant II SYBR Green Single-Step QRT-PCR Master Mix (Agilent
Technologies), with 10 ng of total RNA in 20 µl reaction mixtures [7]. The thermal
profile was 50°C for 30 min, 95°C for 15 min, and then 40 cycles of 95°C for 30 s and
55°C for 30 s. Fluorescence was measured at the end of the 55°C stage of each cycle.
Samples were run in triplicate along with the no-reverse-transcriptase control and the notemplate control. All experiments were repeated twice.
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Statistical analysis. Student's T-tests assuming unequal variances were used for
statistical analyses for all experiments except for the fish infection experiment. P values
of <0.05 were considered statistically significant). A Kaplan-Meier survival analysis with
log rank significance test was performed on the survival percentage in the fish infection
experiment. P values of <0.05 were considered statistically significant.
Results
icd mutant grew to the same cell density limit as wild type in complex media. A V.
anguillarum M93Sm icd mutant was previously shown to grow to a lower cell density
than the wild type in nutrient rich media (e.g. LB20 and NSSM) [11]. A V. anguillarum
NB10Sm icd insertional mutant was constructed and Fig. 2A shows a typical growth
curve for the wild type (NB10Sm) and the icd mutant. Unlike the previously described
M93Sm icd mutant, the NB10Sm icd had a slower growth rate during mid and late
exponential phase growth compared to the wild type but reached the same cell density
after growth for 24 h (Table 3, Supplementary Fig. 4) [11]. No additional copies of icd
are found in the genome and the NB10Sm icd mutant was unable to grow in minimal
media indicating that there is no promiscuous enzyme that can act as an isocitrate
dehydrogenase (Fig. 2B). To ensure the icd insertional mutant (a merodiploid) did not
resolve to restore the wild type, an icd deletion strain was created and showed no
difference in growth compared to the icd insertional mutant (Fig. 2C). The data suggest
that unlike the M93Sm icd mutant, the NB10Sm icd mutant can obtain enough αketoglutarate derivatives (e.g. glutamate, glutamine, and peptides containing those amino
acids) from LB20 to grow to a wild type final cell density.
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icd mutant exhibits at a wild type growth rate when LB20 is supplemented with
gluconate or glutamate. Fig. 3 shows the typical growth curve of the wild type
(NB10Sm) (black) and the icd mutant (blue) in LB20 not supplemented (Fig. 3, dashed
lines) or supplemented with 101.7 mM gluconate (Fig. 3A, solid lines) or 118 mM
glutamate (Fig. 3B, solid lines). The data indicate that the icd mutant exhibited a growth
rate during the mid and late exponential growth phases similar to the wild type when
LB20 was supplemented with a metabolite that feeds into central metabolism upstream
(gluconate) or downstream (glutamate) of the icd mutation (Table 3). Interestingly, the
wild type grew to a higher cell density than the icd mutant when LB20 was supplemented
with gluconate. The data suggests that under these conditions the icd mutant will utilize
gluconate to grow rapidly but will experience a cell density limitation when the cells
exhaust the available glutamate.
A ΔCUO icd mutant has the same growth phenotype as the icd mutant. The CUO
(citrate utilization operons) is a ~17.9 kbp region of the NB10 genome, consisting of
multiple genes and operons: a citrate lyase operon (accession numbers:
WP_013856981.1, WP_013856980.1, WP_013856979.1 ), an ACP synthase (accession
number: WP_013856979.1), an oxaloacetate decarboxylase operon (accession numbers:
WP_013856986.1 and WP_029189993.1), a chemotaxis protein and kinase (accession
number: WP_013856983.1 and WP_013856984.1), and a tri-carboxylate importer operon
(accession numbers: WP_013856993.1, WP_019281353.1, and WP_013856991.1). The
CUO is not present in the M93Sm genome and may provide an alternative to the
glyoxylate shunt to prevent the intracellular buildup of citrate. Interestingly, the upstream
genes (accession numbers: WP_013856977.1, WP_017049831.1, WP_019282875.1, and
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WP_019282876.1) and downstream genes (accession numbers: WP_017046166.1 and
ASO29090.1) flanking this region in the NB10Sm genome are homologous to
neighboring genes in the M93Sm genome indicating an occurrence of a gain of function
(NB10Sm) or loss of function (M93Sm) (Supplementary Fig. 2). The CUO region was
deleted to determine if it enabled the NB10Sm icd mutant grow to a final cell density that
was similar to the wild type. Fig. 4 shows a typical growth curve of the wild type
(NB10Sm), the icd mutant, the ΔCUO mutant and the ΔCUO icd mutant. The ΔCUO
mutant had a growth curve nearly identical to the wild type and the ΔCUO icd mutant
had a growth curve that was nearly identical to the icd mutant indicating that the presence
of the CUOs did not enable the NB10Sm icd mutant to reach to a wild type cell density
after 24 h.
icd mutant is as virulent as the wild type against juvenile rainbow trout. To
determine if the NB10Sm icd mutant would be as virulent as the wild type (NB10Sm), 10
juvenile rainbow trout were challenged via immersion at a dose of between 6.5×106
CFU/ml to 9.4×106 CFU/ml (Table 4). Although it took seven days for the icd mutant to
cause 70% morality and five days for the wild type to cause 80% mortality, there was no
statistically significant difference in virulence between the two strains (P= 0.30).
sucA mutant, fumA mutant, and a ΔfrdA sdhC mutant grow to a final cell density in
complex media lower than the wild type. It was previously proposed that a decreased
final cell density in complex media resulting from a nutrient limitation in vitro could
correlate to attenuation in virulence in vivo [11]. Since the NB10Sm icd mutant did not
show either a decrease in final cell density or a loss of virulence, an additional ten central
metabolism single and double mutants were created in the following genes: cra, gltA,
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Δicd gltA, sucA, sucC, sdhC, ΔfrdA, ΔfrdA sdhC, and fumA (Table 1). Fig. 5A shows a
typical growth curve of the wild type (NB10Sm) and various central metabolism mutants.
Examination of the growth yield for the various mutant strains after 24 h by optical
density shows that the sucA mutant (OD600 = 0.551), fumA mutant (OD600 = 0.618), and a
ΔfrdA sdhC mutant (OD600 = 0.482) failed to grow to a wild type (OD600 = 1.08) cell
density (Fig. 5B). The sucA mutant and the ΔfrdA sdhC mutant have a large standard
deviation at the 24 h time point that could have resulted from the strains resolving the
merodiploid present in the sucA or sdhC gene. Supplementary Fig. 3 demonstrates how
this reversion to a wild type phenotype could occur when the insertional mutant strains
are grown in the absence of the antibiotic chloramphenicol.
Supplementing LB20 with additional nutrients restores growth of the ΔfrdA ΔsdhC
mutant but not the ΔsucA mutant to wild type levels. Fig 6A shows the final cell
density (OD600) of the wild type (NB10Sm), ΔfrdA ΔsdhC mutant and the ΔsucA mutant
after growth for 24 h and 48 h in LB20. The deletion mutations were shown to be stable
because the standard deviation between biological repeats was nearly nonexistent and
there was no increase in growth between 24 h and 48 h. The two mutant strains were
further screened via colony PCR using primers specific to the pJM1 plasmid to ensure the
decreased growth yield did not result from loss of this plasmid (data not shown). Fig 6B
shows the final cell density (OD600) of the wild type and the ΔfrdA ΔsdhC mutant grown
in LB20 or LB20 supplemented with succinic acid (118 mM), gluconate (118 mM),
malate (118 mM) or aspartate (118 mM). The data indicate that the addition of malate or
aspartate increased the growth of the ΔfrdA ΔsdhC mutant to near wild type level.
Although the ΔfrdA ΔsdhC mutant cannot convert succinate to fumarate, it is not
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auxotrophic for any metabolite. Fig. 6C shows the 24 h cell density (OD600) of the wild
type and ΔsucA mutant grown in LB20 or LB20 supplemented with lysine (118 mM) or
DL-α, ɛ-diaminopimelic acid (118 mM) or lysine, DL-α, ɛ-diaminopimelic acid, and
methionine (118 mM). The ΔsucA mutant is auxotrophic for the TCA cycle intermediate
succinyl-CoA, a metabolite that is needed in diaminopimelic acid, lysine and methionine
biosynthesis [40]. The addition of lysine, DL-α, ɛ-diaminopimelic acid and methionine to
LB20 did not restore the growth of the ΔsucA mutant to a wild type cell density and
indicates that the cells are either unable to import lysine or DL-α, ɛ-diaminopimelic acid
or methionine or the cells require metabolites upstream of diaminopimelic acid in the
biosynthetic pathway of lysine and the enzymes involved in this pathway cannot run in
reverse. Interestingly, the addition of lysine and DAP actually caused the wild type to
grow to a lower cell density, indicating that these cells do not favor these metabolites for
growth.
The ΔsucA mutant and the ΔfrdA ΔsdhC mutant grow to a lower cell density
compared to the wild type in various types of complex media. The final cell densities
(CFU/ml) of the wild type (NB10Sm), ΔsucA mutant and the ΔfrdA ΔsdhC mutant were
determined after 24 h of growth in four forms of complex media: LB20, NSSM, Spleen
extract medium, and NSSSkM (Table 6). In all forms of complex media, the ΔsucA
mutant grew to the lowest cell density followed by the ΔfrdA ΔsdhC mutant.
All mutants exhibited either same or lower expression levels of the three hemolysin
genes compared to wild type. Vah1, RtxA, and Plp are three hemolysins secreted by V.
anguillarum M93Sm that have been characterized and determined to be responsible for
the hemolytic/cytolytic activity against fish erythrocytes, leukocyte and epithelial cells [7,
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9, 41] and unpublished data]. It is unknown how these hemolysins contribute to the
virulence of V. anguillarum NB10Sm. The expression of vah1, rtxA and plp during
exponential phase was tested to determine whether mutations in metabolism could affect
the expression of these hemolysin genes (Fig. 7A). rtxA was the most highly expressed
(>4.6×103 copies/10 ng RNA) of the three hemolysins in NB10Sm and there was no
statistically significant difference between the wild type (NB10Sm) and the two mutants
(ΔsucA and ΔfrdA ΔsdhC). The mutants have a decrease in expression in both plp and
vah1 compared to the wild type. However, these genes were expressed at the limit of
detection by qRT-PCR. In the wild type, there were <30 copies/10 ng RNA for plp and
<10 copies/10 ng RNA for vah1.
All mutants exhibited lower levels of empA metalloprotease gene expression
compared to wild type. It has previously been demonstrated that V. anguillarum NB10
empA metalloprotease mutants are slightly attenuated in virulence and that empA
expression is dependent upon RpoS and, therefore, highly expressed during stationary
phase [6, 42, 43]. The expression of empA during stationary phase was tested to
determine whether mutations in metabolism could affect the expression of this gene (Fig.
7B). There was a ~3000-fold decrease in the expression of empA in the ΔsucA mutant and
a 23-fold decease in the ΔfrdA ΔsdhC mutant compared to the wild type (NB10Sm). Both
decreases in expression were statistically significant (P = 0.008 and P = 0.01
respectively). The data indicate that mutations in central metabolism can cause a decrease
in the expression of the metalloprotease empA.
ΔsucA mutant and the ΔfrdA ΔsdhC mutant are as virulent as the wild type against
juvenile rainbow trout. To determine if the ΔsucA mutant and the ΔfrdA ΔsdhC mutant
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would be as virulent as the wild type (NB10Sm), 5 juvenile rainbow trout were
challenged via immersion at a dose of between 1.0×106 CFU/ml to 4.0×106 CFU/ml
(Table 7). There was no statistically significant difference in mortality between fish
challenged with the wild type (100%) and the ΔsucA mutant (100%) (P= 0.39) or ΔfrdA
ΔsdhC mutant (100%) (P= 0.65). The data once again indicate that central metabolism
mutants that have a lowered final cell density due to a starvation of a nutrient will not
necessarily be attenuated in virulence.
Discussion
A V. anguillarum M93Sm icd mutant (O2α serotype) was previously shown to be
attenuated in virulence and elicit an immunoprotective response in juvenile rainbow trout
[11]. Though, V. anguillarum is an extracellular pathogen, the attenuation was thought to
have resulted from the inability of the mutant to synthesize α-ketoglutarate and its amino
acid derivatives (i.e. glutamate and glutamine). Subsequently, we demonstrated that a
M93Sm ΔgltA mutant, also auxotrophic for glutamate, exhibited no reduction in
virulence in vivo. Unlike the previously reported intracellular pathogens, the attenuation
in virulence of the icd mutant is likely to involve more than just a simple nutrient
starvation [12-27] [Spinard, EJ et al, in preparation, chapter 2 of this manuscript 2017].
Regardless of the cause of the attenuation of the M93Sm icd mutant, it was still
immunoprotective and has potential as a live cell vaccine against vibriosis. V.
anguillarum vaccines must be multivalent in order to fully protect against vibriosis
caused by all V. anguillarum serotypes (O1, O2, O3) implicated in disease [30].
Accordingly, this study originally sought to create a live attenuated O1 serotype strain by
mutating icd in V. anguillarum NB10Sm. The NB10Sm icd mutant (the insertional
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mutant and the deletion mutant) did not show the cell density limitation previously
observed in the M93Sm icd mutant in complex media (Fig. 2) nor was it reduced in
virulence against juvenile rainbow trout (Table 4) [11]. The NB10Sm icd mutant (ES920
and ES926) did have a longer generation time than the wild type during mid and late
exponential growth that was shortened by the addition of gluconate or glutamate to LB20.
The data suggest that the decrease in growth rate of the NB10Sm icd mutant (ES920)
occurs because the cells are required to utilize unfavorable metabolites or perform
energetically unfavorable reactions during the mid and late exponential growth phase that
can be alleviated by the addition of an extra energy source (gluconate) or metabolite that
cannot be synthesized (glutamate). It is not clear why the V. anguillarum NB10Sm icd
mutant is not starved for α-ketoglutarate like the M93Sm icd mutant. One explanation
could be linked to the higher expression levels of the empA metalloprotease in V.
anguillarum NB10 compared to V. anguillarum M93Sm in noninduced (LB20)
conditions [6]. LB20 is composed of yeast extract and tryptone (both of which are
composed of peptides of varying sizes), although bacteria can only utilize peptides that
are six amino acids in size or smaller [44, 45]. The increase in expression of empA could
allow the NB10Sm icd mutant (ES920) to more efficiently break down and utilize
proteins and large sized peptides than M93Sm, preventing the cells from being starved
for glutamate.
Since the NB10Sm icd mutant (ES920) was not attenuated in virulence and did
not have a final cell density limit that was lower than the wild type after 24 h of growth in
complex media, additional central metabolism mutants and double mutants were
constructed (Table 1). Mutations in fumA, sucA or ΔfrdA sdhC caused reductions in the
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final cell density (Fig. 5). Focus was placed on the sucA mutant and the ΔfrdA sdhC
mutant and deletion mutants were constructed for each strain to prevent the mutants from
spontaneously resolving the merodiploid (a phenomenon that was previously exploited to
create the icd revertant strain [11]). The ΔfrdA ΔsdhC mutant can run the reductive and
oxidative branch of the TCA cycle to synthesize any intermediate and accordingly, is not
auxotrophic for any metabolite when it is grown with glucose as the only carbon source.
However, the data suggest that the cells favor metabolites that feed into the TCA cycle at
α-ketoglutarate such as glutamate and glutamine. Since the TCA cycle can only run αketoglutarate to succinate (the reaction catalyzed by icd is nonreversible), the cells are
starved for the amino acid aspartate. The growth limitation of the ΔsucA mutant was not
fully characterized but is presumed to have resulted from the inability of the cells to
synthesize succinyl-CoA, a metabolite utilized in the biosynthetic pathways for the
production of diaminopimelic acid, lysine and methionine [40]. The initial hypothesized
route of infection for V. anguillarum NB10Sm is through the skin, gills or anus of the fish
where it enters the circulatory system and accumulates in the spleen [4, 5]. Accordingly,
the final cell densities of the ΔsucA mutant and ΔfrdA ΔsdhC mutant were determined in
media that represent early infection (NSSM and NSSSkM) and mid-infection (spleen
extract medium). In all forms of complex media (including LB20 as a control) the ΔsucA
mutant grew to the lowest cell density, followed by the ΔfrdA ΔsdhC mutant (Table 6).
The data suggests that, even under ideal conditions at each point of the infection process,
the mutants could be starved for essential metabolites in vivo. However, the infection
experiments (Table 7) demonstrate that the starvation does not correlate to a loss of
virulence in vivo (discussed below).
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The expression of the virulence factors (rtxA, plp, vah1, empA) were examined in
the ΔsucA mutant and ΔfrdA ΔsdhC mutant and compared to the wild type (Fig. 7). NB10
has been previously been shown to be non-hemolytic on blood agar, presumably from the
hemolysins being degraded by EmpA before they can lyse the red blood cells [9]. This
study expands upon this explanation and shows that the actual expression levels of the
hemolysins is much lower in NB10Sm compared to M93Sm. Expression of rtxA during
log phase was relatively similar between the wild type and the mutants, although a
decrease in expression was observed for plp and vah1 (Fig. 7). This decrease was not
believed to be relevant since the expression of plp and vah1 was very low in the wild type
(28 and 6.5 copies per 10 ng of total RNA, respectively). It has previously been shown
that a V. anguillarum M93Sm rtxA mutant is avirulent [7]. It is not known how rtxA
contributes to the virulence of V. anguillarum NB10Sm especially since the RtxA of
M93Sm and NB10Sm have different effector domains [46]. This study demonstrates that
the expression of rtxA is 127-fold lower than in M93Sm [Spinard, EJ et al, in preparation,
chapter 2 of this manuscript]. Yet, the expression of NB10Sm rtxA was still 160-fold
higher than the expression of NB10Sm plp suggesting that it could be important for the
infection process of NB10Sm. Expression of the metalloprotease empA was examined
during stationary phase. empA has been shown to be nonessential for the virulence of V.
anguillarum NB10 [42, 47]. It has previously been demonstrated that the expression of
empA is cell density dependent [6]. Accordingly, the ΔsucA mutant had the lowest final
cell density (13% of the wild type) and the lowest expression level of empA (0.03% of the
wild type). The transcript of VanT, the transcriptional activator of empA, is stabilized by
the sigma factor RpoS [43, 47]. Alternatively, the decrease in expression of empA in the
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mutants could have resulted from a decrease in expression of RpoS.
Regardless of the lowered cell density limit and the decrease in empA production,
both the ΔsucA mutant and ΔfrdA ΔsdhC mutant were as virulent as the wild type in
juvenile rainbow trout (Table 7). The metabolite starvation that prevents the mutants
from reaching a wild type growth yield in vitro does not prevent the cells from reaching
the threshold needed to cause disease in vivo. Accordingly, the approach that was used in
this study to find attenuated strains, screening central metabolism mutants that grow to a
lower cell density than the wild type in vitro, was unsuccessful probably because V.
anguillarum is an extracellular pathogen that grows in the nutrient rich mucus of the skin
or intestines. Still, nutrient starvation must affect the infection process of V. anguillarum
and contribute to attenuation of the previously reported M93Sm icd mutant (decreased
final cell density compared to the wild type). If it did not, it would have been expected
that the NB10Sm icd mutant (same final cell density as the wild type) would have been
attenuated. Yet, there must be other unknown factors besides nutrient starvation that are
contributing to the reduction of virulence seen in V. anguillarum M93Sm icd mutant or
else the previously reported M93Sm ΔgltA mutant, that experiences the same starvation
for glutamate as the icd mutant, would have been attenuated. Further studies must be
performed with the M93Sm icd mutant to fully understand the cause of attenuation.
Conclusions
Multiple central metabolism mutants and double mutants were constructed in V.
anguillarum NB10Sm. Unlike the previously described V. anguillarum M93Sm icd
mutant, the NB10Sm icd mutant was as virulent as the wild type. Although both the
ΔsucA mutant and ΔfrdA ΔsdhC mutant grew to lower cell densities than the wild type in
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several forms of complex media and had large and significant decreases in expression of
the empA metalloprotease, neither strain was attenuated in virulence. Compared to plp
and vah1, there was higher expression in the gene encoding the MARTX toxin rtxA,
suggesting that rtxA may contribute to the virulence of NB10Sm. The data demonstrate
that strain specific phenotypes may result even if mutations are made in the same highly
conserved gene.
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Table 1. Bacterial strains and plasmids used in this study
Strain or
Description
plasmid

Reference

V.
anguillarum
strains
NB10Sm
Spontaneous Smr mutant of NB10 (serotype O1)
SM920
Smr Cmr; icd insertional mutant
ES926
Smr Kmr; icd allelic exchange mutant
Smr Cmr Kmr; icd allelic exchange, gltA insertional double
ES926.990
mutant
ES930
Smr Cmr; cra insertional mutant
ES940
Smr Cmr; sucA insertional mutant
ES946
Smr Kmr; sucA allelic exchange mutant
ES950
Smr Cmr; sucC insertional mutant
ES960
Smr Cmr; sdhC insertional mutant
ES970
Smr Cmr; fumA insertional mutant
ES985
Smr Cmr Kmr; frdA insertional mutant
ES986
Smr Kmr; frdA allelic exchange mutant
Smr Kmr; frdA allelic exchange, sdhC allelic exchange
ES986.966
double mutant
ES990
Smr Cmr; gltA insertional mutant
ES2546
Smr Kmr; CUO allelic exchange mutant
Smr Cmr Kmr; CUO allelic exchange icd insertional double
ES2546.920
mutant
E. coli strains
Sm10
thi thr leu tonA lacY supE recA RP4-2-Tc::Mu::Km (λ pir)
S100
Kmr; Sm10 containing plasmid pNQ705-1
Q925
Kmr Cmr; Sm10 containing plasmid pDM4-icd
Q420
Kmr Cmr; Sm10 containing plasmid pNQ705-icd
Q440
Kmr Cmr; Sm10 containing plasmid pNQ705-sucA
Q450
Kmr Cmr; Sm10 containing plasmid pNQ705-sucC
Q460
Kmr Cmr; Sm10 containing plasmid pNQ705-sdhC
Q470
Kmr Cmr; Sm10 containing plasmid pNQ705-fumA
Q430
Kmr Cmr; Sm10 containing plasmid pNQ705-cra
Q990
Kmr Cmr; Sm10 containing plasmid pNQ705-gltA
Q945
Kmr Cmr; Sm10 containing plasmid pDM4-sucA
Q2545
Kmr Cmr; Sm10 containing plasmid pDM4-CUO
Q985
Kmr Cmr; Sm10 containing plasmid pDM4-frdA
Q965
Kmr Cmr; Sm10 containing plasmid pDM4-sdhC
Plasmid
pNQ705-1
Cmr; suicide vector with R6K origin
pDM4
Cmr Kmr SacBC; suicide vector
pNQ705-gltA
Cmr; For gltA insertional mutant
pNQ705-icd
Cmr; For icd insertional mutant
pNQ705-sucA Cmr; For sucA insertional mutant
pNQ705-sucC Cmr; For sucC insertional mutant
pNQ705-sdhC Cmr; For sdhC insertional mutant
pNQ705-fumA Cmr; For fumA insertional mutant
pNQ705-cra
Cmr; For cra insertional mutant
pDM4-icd
Cmr Kmr SacBC; For icd deletion mutant
pDM4-sucA
Cmr Kmr SacBC; For sucA deletion mutant
pDM4-CUO
Cmr Kmr SacBC; For CUO deletion mutant
pDM4-sdhC
Cmr SacBC; For sdhC deletion mutant
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[42]
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
[48]
[49]
This study
[11]
[11]
[11]
[11]
[11]
[11]
This study
This study
This study
This study
This study
[49]
[35]
This study
[14]
[14]
[14]
[14]
[14]
[14]
This study
This study
This study
This study

Table 2. Primers used in this study.
Primer
pr31
pr32
pr50
pr51
pr52
pr53
pr54
pr55
pr56
pr57
pm110
pm111
pr33
pr34
pm119
pm120
pm121
pm122
PmG-13
PmG-14
PmG-15

Sequence (5' to 3')1, 2

Description

Reference

GGTGAGCTCTATTCTTTATTGCCGATTATC
AAATCTAGAGTAAGTCGCTTTAATCGCTTC
AAAGAGCTCGTGATCCAGATGTCGATGCTA
GGTTCTAGAGTTCAGTGTCGATAATGTGCA
AAAGAGCTCGGTCGGATTAGTACAGCGAAG
GGTTCTAGACTTTTTCAATTTCCACGCCGC
AAAGAGCTCATGTTCGTTGCGGTCGGAATT
GGTTCTAGATCCAACTCTTCAAAGTGGCCC
GGTGAGCTCTCCTTGCACCATATTGATATG
GGGTCTAGAAGGCTTATCATCGAGAAGAGAG
GGCGAGCTCTCGATGGCGAAAAAG
GGCTCTAGAGCTCGTGGACCAT
AAAGAGCTCGCGGCGTGAGACTAAGGCATC
AAATCTAGACAATGGCAAAGCGCAGAAGTA
GCCGAGCTCTTTGTTCTGCTGGCTTTTTA
GCCTCTAGAGGGATTTTGTTGGAAGTTGA
GGCCTCGAGCTTAACTGTCATTCAGCCTC
GGCGCTAGCGTGGAGGCTCTCTTTCTTAT

For icd insertional mutant, forward, SacI
[14]
For icd insertional mutant, reverse, XbaI
[14]
For sucA insertional mutant, forward, SacI
[14]
For sucA insertional mutant, reverse, XbaI
[14]
For sucC insertional mutant, forward, SacI
[14]
For sucC insertional mutant, reverse, XbaI
[14]
For sdhC insertional mutant, forward, SacI
[14]
For sdhC insertional mutant, reverse, XbaI
[14]
For fumA insertional mutant, forward, SacI
[14]
For fumA insertional mutant, reverse, XbaI
[14]
For gltA insertional mutant, forward, SacI This study
For gltA insertional mutant, reverse, XbaI This study
For cra insertional mutant, forward, SacI
[14]
For cra insertional mutant, reverse, XbaI
[14]
For CUO 5' region, forward, sac1
This study
For CUO 5' region, reverse xba1
This study
For CUO 3' region, forward, xhoI
This study
For CUO 3' region, reverse nheI
This study
For sdhC 5' region, forward, Gibson
aatcccgggaGAGCTCCGTGAAAGAAAGAAAGTCAAGACCTG
assembly
This study
For sdhC 5' region, reverse, Gibson
aaatggcgACCCCAGACACTCGGTGTAG
assembly
This study
For sdhC 3' region, forward, Gibson
tctggggtCGCCATTTGCTGATGGACC
assembly
This study
For sdhC 3' region, reverse, Gibson
cgggtaacctGAGCTCTAAAACTGAAAGCACTGCTGTTGC
assembly
This study
For icd 5'region, reverse, xba1
TTAATTTCTAGATGATAATGGTGCGCGGCGATC
This study
For icd 3' region, forward, xho1
TAATAACTCGAGAAAGCACGGCGCATTTGATCC
This study
ACTGCTGCTAGCGAATAGATCCGTGAGGTAATC
For icd 3' region, reverse, nhe1
This study
For sucA 3' region, forward, xho1
GCACTCGAGTCTGGTTTGTTATCGCCGTC
This study
GTAGCTAGCGCGGATTCGCTTTCCATCAT
For sucA 3' region, reverse, nhe1
This study
GTAGAGCTCGGAGGCTCAGCAGCAGTTAT
For frdA 5' region, forward, sacI
This study
GATTCTAGAGAAGAGGGTGTGCAGCATGT
For frdA 5' region, reverse, xbaI
This study
CTACTCGAGTTCGCACTGAGATGGGTCAC
For frdA 3' region, forward, xhoI
This study
GTTGCTAGCTCGATACTTGGAGCGGCATC
For frdA 3' region, reverse, nheI
This study
CGGCTATCTAGAGAAAAGCTTGAACACGTAGAA
For KanR forward, XbaI
GCATTACTCGAGCGTTTCTGGGTGAGCAAAAAC
For KanR reverse, xhoI
GTTTGGTATGGAACACCGCTCAAG
For vah1 qRT-PCR, forward
Reference
GGCTCAACCTCTCCTTGTAACCAA
For vah1 qRT-PCR, reverse
Reference
CAGACGACCACCAGTAACCACTAA
For plp qRT-PCR, forward
Reference
GCAATCATGATGACCCAGCAACAG
For plp qRT-PCR, reverse
Reference
GGAAATTATTCCGCCGACGATGGA
For rtxA qRT-PCR, forward
Reference
GCCGATACCGTATCGTTACCTGAA
For rtxA qRT-PCR, reverse
Reference

PmG-16
pr68
pr69
pr70NheI
pm64suc
pm65suc
pm76
pm77
pm78
pm79
pm38
pm39
vah1 F RT
vah1 R RT
plp F RT
plp R RT
Pm111
Pm112
empA-qRT-PCRTCAAATCTTCCGGTGGCTTACGTT
F
empA-qRT-PCRGCGCGATTAAACACACCACTTGAA
R
1lowercase sequences are designed to be homologous to flanking sequences
2underlined sequences are designed to be restriction enzyme cut sites
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For empA qRT-PCR, forward

Reference

For empA qRT-PCR, reverse

Reference

Table 3. Generation times of various V. anguillarum strains grown in LB201
Early Exponential Phase
Mid Exponential Phase
Strain
(Minutes)
(Minutes)
LB20

Gluconate

Glutamate

LB20

Gluconate

Glutamate

Late Exponential Phase
(Minutes)
LB20

Gluconate

NB10Sm
55
65
74
98
84
84
105
99
icd
55
63
68
108
76
83
107
97
(ES920)
1
Values calculated from data presented in Figure 2A and Figure 3 during exponential growth.
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Glutamate

102
101

Table 4. Virulence of V. anguillarum strains in juvenile rainbow trout
Dosage
Total
No. of days until death (No. of fish /
Strain
(CFU/ml)
Mortality
total)
NB10Sm

7.2-9.4×106

80%

icd (ES920)

6.5-6.9×106

70%

2 (6/10) 3 (5/10) 4 (6/10) 5 (8/10)
2 (1/10) 3 (3/10) 4 (4/10) 5 (5/10) 7
(7/10)

0%

NA

NSS
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Table 5. Generation times of various V. anguillarum strains grown in LB201
Early Exponential Phase
Late Exponential Phase
Strain
(Minutes)
(Minutes)
NB10Sm
55
102
icd (ES920)
45
102
gltA
51
100
Δicd gltA
54
103
cra
52
102
sucA
55
115
sucC
67
107
sdhC
58
109
fumA
57
108
ΔfrdA
60
101
ΔfrdA sdhC
58
113
1
Values calculated from data presented in Figure 5A during exponential growth.
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Table 6. Final cell density (CFU/ml) of various V. anguillarum cultures grown for 24 h
Strain

CFU/ml in LB20

CFU/ml in NSSM
(200µg/ml)

CFU/ml in Spleen

CFU/ml in NSSSkM
(200µg/ml)

NB10Sm

7.8×109 (±1.1×109)

7.2×109 (±0.9×108)

1.5×108 (±0.2×108)

1.6×109 (±0.3×108)

ΔsucA

1.0×109 (±0.9×109)**

4.6×108 (±2.7×108)**

1.2×107 (±0.8×107)**

ΔfrdA
ΔsdhC

2.2×109 (±0.6×109)*

2.5×109 (±1.2×109)*

7.7×107 (±0.5×107)

3.8×107 (±0.3×108)**
2.2×108 (±0.3×108)**

** statistically significant to wild type (P < 0.01), * statistically significant to wild type (P < 0.05)
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Table 7. Virulence of V. anguillarum strains in juvenile rainbow trout
Dosage
Total
Strain
No. of days until death (No. of fish / total)
(CFU/ml)
Mortality
NB10Sm
4×106
100%
2 (3/5) 3 (4/5) 4 (5/5)
ΔsucA

3.5×106

100%

2 (1/5) 3 (4/5) 5 (5/5)

ΔfrdA ΔsdhC

1.×106

100%

2 (4/5) 3 (5/5)

NSS

NA

0%

NA
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TABLE 8. Comparison of all mutant V. anguillarum strains
Strain Information

Growth Characteristics

Gene Expression

Final Growth Yield
Name

Gene

Mutation
Type

Parental
Strain

Growth
Rate

LB20

3M +
0.15%
Glucose

NSSM

Spleen

NSSSkM

Virulent
in
rainbow
trout

Auxotrophic

rtxA

plp

vah1

prpC

empA

+

+

+

ND

ND

+

+

+

+

ND

ND

-

+

++

+

ND

ND

+

+

++

++

ND

ND

+

XM410

mdh

ID

M93Sm

-

+

+

ND

ND

ND

XM420

icd

ID

M93Sm

+

-

-

-

ND

ND

XM430

cra

ID

M93Sm

+

+

+

ND

ND

ND

XM440

sucA

ID

M93Sm

-

+

-

ND

ND

ND

XM450

sucC

ID

M93Sm

-

+

+

ND

ND

ND

ND
αketoglutarate
derivatives
ND
Succinyl
CoA
derivatives
ND

+

++

++

ND

ND

+

XM460

sdhC

ID

M93Sm

-

+

+

ND

ND

ND

ND

+

++

++

ND

ND

+

XM470

fumA

ID

M93Sm

-

+

+

ND

ND

ND

ND

+

+

++

ND

ND

+

ES422

icd

NA

XM420

+

+

+

ND

ND

ND

ND

ND

ND

ND

ND

+

ES496

gltA

AE

M93Sm

+

-

±

-

-

ND

+

+

+

+

ND

+

ES3-2

gltA,
prpR

AE,
R66L

M93Sm

+

-

+

-

+

ND

ND

ND

ND

++

ND

+

ES496.6600

gltA,
prpC,
prpR

AE, AE,
R66L

M93Sm

+

-

-

-

-

ND

ND
αketoglutarate
derivatives
αketoglutarate
derivatives
αketoglutarate
derivatives

ND

ND

ND

ND

ND

+

ES6600

prpC

AE

M93Sm

+

+

+

ND

+

ND

ND

ND

ND

ND

ND

+

ES920

icd

ID

NB10Sm

-

+

-

ND

ND

ND

ND

ND

ND

ND

ND

+

ES926

icd

AE

NB10Sm

-

+

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ES926.990

icd,
gltA

AE, ID

NB10Sm

+

+

ND

ND

ND

ND

ND
αketoglutarate
derivatives
αketoglutarate
derivatives
αketoglutarate
derivatives

ND

ND

ND

ND

ND

ND

ES930

cra

ID

NB10Sm

+

+

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

+

-

-

ND

-

+

succinyl
CoA
derivatives
succinyl
CoA
derivatives

ES940

sucA

ID

NB10Sm

-

-

ND

ND

ND

ND

ES946

sucA

ID

NB10Sm

ND

-

ND

-

-

-

ES950

sucC

ID

NB10Sm

-

+

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ES960

sdhC

ID

NB10Sm

-

-

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ES970

fumA

ID

NB10Sm

-

-

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ES986

frdA

AE

NB10Sm

+

+

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

AE, ID

NB10Sm

-

-

ND

ND

ND

ND

aspartate

ND

ND

ND

ND

ND

ND

AE, AE

NB10Sm

ND

-

ND

-

+

-

aspartate

+

+

-

-

+

ND

ND

ND

ND

ND

ND

ES986.960
ES986.966

frdA,
sdhC
frdA,
sdhC

ND

ES990

gltA

ID

NB10Sm

+

+

ND

ND

ND

ND

αketoglutarate
derivatives

ES2546

CUOs

AE

NB10Sm

+

+

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ES2546.920

CUOs
icd

ND

αketoglutarate
derivatives

ND

ND

ND

ND

ND

ND

AE, ID

NB10Sm

-

+

ND

ND

ID: Insertional Deletion (merodiploid capable of restoring to a wild type genotype)
AE: Allelic Exchange
NA: Not Applicable
ND: Not Determined
CUO: Citrate Utilization Operon
+ Wild type level
++ Greater than wild type
- Less than Wild type
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ND

Figure Legends
Figure 1. Embden-Meyerhoff-Parnas Pathway, TCA cycle, and metabolism of fructose.
The arrows indicate the physiological directions of the reactions. The gene symbols of the
enzyme for each reaction are listed beside the reaction. Boxed genes indicate the genes
that were mutated in this study (Table 1).
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Glucose
Fructose-1-P

fruA/B

fruP

Fructose-1,6-P
cra

Phosphoenolpyruvate

Acetyl-CoA
gltA

Oxaloacetate

Citrate

mdh

Aspartate

acn
B

Isocitrate

Malate

icd

fumA

-Ketoglutarate

Fumarate
frdABCD

sucAB

sdhCDAB

Succinate

Succinyl-CoA
sucCD

125

Fructose

Figure 2. Growth of V. anguillarum WT (NB10Sm) and the icd mutant (ES920) under
various conditions. Growth curves of V. anguillarum strains NB10Sm and the icd mutant
in LB20 at 27°C with shaking (200 rpm). At various time points after inoculation samples
were taken for determination of optical density at 600 nm (OD600). The data are the
average of two independent experiments. Error bars represent 1 standard deviation. B)
Final cell densities (OD600) of V. anguillarum strains NB10Sm and the icd mutant after 24
h of growth in 3M plus 0.15% glucose supplemented with or without 2 mM glutamate or
2 mM glutamine. In each experiment cells grown overnight in LB20 were washed in NSS
o

and used to inoculate the appropriate media. Cultures were incubated at 27 C in a shaking
water bath (200 rpm) and at various time points after inoculation samples were taken for
determination of optical density at 600 nm (OD600).
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Figure 3. Growth of V. anguillarum WT (NB10Sm) and the icd mutant under various
conditions. A) Growth curves of V. anguillarum NB10Sm (black) and the icd mutant
(blue) in LB20 (dashed lines) or LB20 supplemented with 101.7 mM gluconate (solid
lines). B) Growth curves of V. anguillarum NB10Sm (black) and the icd mutant (blue) in
LB20 (dashed lines) or LB20 supplemented with 118 mM glutamate (solid lines). In each
experiment cells grown overnight in LB20 were washed in NSS and used to inoculate the
o

appropriate media. Cultures were incubated at 27 C in a shaking water bath (200 rpm)
and at various time points after inoculation samples were taken for determination of
optical density at 600 nm (OD600). The data are the average of two independent
experiments. Different letters indicate statistical significance among groups (P < 0.05).
Statistical analysis was based on data at 24 h. Error bars represent 1 standard deviation.
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Figure 4. Growth curves of various V. anguillarum strains grown in LB20 at 27°C with
shaking (200 rpm). At various time points after inoculation samples were taken for
determination of optical density at 600 nm (OD600). The data are the average of two
independent experiments. Error bars represent 1 standard deviation.
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Figure 5. Growth of various V. anguillarum strains grown in LB20 at 27°C with shaking
(200 rpm). A) Growth curve of various V. anguillarum strains. At various time points
after inoculation samples were taken for determination of optical density at 600 nm
(OD600). B) Examination of the 24 h time point from Figure 5A. The data are the average
of two independent experiments. Between marked strains and NB10Sm: * P < 0.05 and
*** P < 0.001. Error bars represent 1 standard deviation.
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A

1.5

OD600

1

0.5

0
0
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sucA
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icd
sucC
frdA sdhC
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Time (h)
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20
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cra
fumA

Figure 6. Growth of V. anguillarum WT (NB10Sm) the ΔsucA mutant and the ΔfrdA
ΔsdhC mutant under various conditions. A) Final cell densities (OD600) of V. anguillarum
strains NB10Sm, the ΔsucA mutant and the ΔfrdA ΔsdhC mutant after 24 h or 48 h of
growth in LB20. B) Final cell densities (OD600) of V. anguillarum strains NB10Sm and
the ΔfrdA ΔsdhC mutant after growth for 24 h in LB20 with or without the addition of
either succinic acid (118 mM), gluconate acid (118mM), malate acid (118 mM), or
aspartate acid (118 mM). C) Final cell densities (OD600) of V. anguillarum strains
NB10Sm and the ΔsucA mutant after 24 h of growth in LB20 with or without the addition
of either lysine (118 mM) or DL-α, ɛ-Diaminopimelic acid. In each experiment cells
grown overnight in LB20 were washed in NSS and used to inoculate the appropriate
o

media. Cultures were incubated at 27 C in a shaking water bath (200 rpm) and at various
time points after inoculation samples were taken for determination of optical density at
600 nm (OD600). The data are the average of two independent experiments. Different
letters indicate statistical significance among groups (P < 0.05). Between marked strains
and NB10Sm grown in LB20: ** P < 0.01, *** P < 0.001 and **** P < 0.0001. Error
bars represent 1 standard deviation. Error bars represent 1 standard deviation.

134

A

OD600

1.5

a

a

24 h

48 h

1
c

0.5

b

c

b

0
NB10Sm

B

NB10Sm ΔsucA

LB20

1.6

OD600

1.2
***
0.8

****
****

0.4
0
NB10Sm

C

NB10Sm ΔfrdA
ΔsdhC

LB20 + 118 mM
succinic acid
LB20 + 118mM
gluconate
LB20 + 118 mM
malate
LB20 + 118 mM
aspartate

NB10Sm ΔfrdA
ΔsdhC

1.5
**

LB20
**

1

OD600

LB20 + 118 mM
lysine
0.5

****
****

****

0
NB10Sm

NB10Sm ΔsucA

135

LB20 + 118 mM DLα,ɛ-Diaminopimelic
acid

Figure 7. mRNA expression levels of various genes. A) Expression of vah1, plp, rtxA determined
by qRT-PCR analysis of V. anguillarum wild-type (NB10Sm), the ΔsucA mutant and the

ΔfrdA ΔsdhC mutant during logarithmic (Log)-phase growth. B) Expression of empA
determined by qRT-PCR analysis of V. anguillarum wild-type (NB10Sm), the ΔsucA mutant

and the ΔfrdA ΔsdhC mutant during stationary phase (Stat)-phase growth. The data presented
are representative of two independent experiments. Each value is the average for six replicates.
Between marked strains and NB10Sm: ** P < 0.01. Error bars represent 1 standard deviation.
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Figure S1. Cell density determined by viable count vs. OD600 of V. anguillarum
NB10Sm. The line indicates linear regression.
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Figure S2. Graphical representation of the CUO region (blue arrows) and flanking genes
(green arrows) in the genomes of V. anguillarum A) NB10 and B) M93Sm. Yellow
arrows represent open reading frames encoding hypothetical proteins.
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141

Figure S3. Graphical representation of a suicide vector inserting into the sucA gene. A)
First a crossover event occurs in the genome and the suicide vector inserts in the 5’
region of sucA. B) If the cells are grown without selection a second cross over event can
occur that will C) resolve the merodiploid and restore the wild type sucA. Figure not
drawn to scale.
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Figure S4. Growth curves of V. anguillarum M93Sm, NB10Sm, and their derived icd
mutant strains grown in LB20 at 27°C with shaking (200 rpm). At various time points
after inoculation samples were taken for determination of optical density at 600 nm
(OD600). The data are the average of two independent experiments. Error bars represent 1
standard deviation.
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Vibrio coralliilyticus RE22 is a causative agent of vibriosis in larval bivalves. We report
the draft genome of V. coralliilyticus RE22 and describe additional virulence factors,
which may provide insight into the mechanism of pathogenicity.
Vibrio coralliilyticus RE22 (formally Vibrio tubiashii RE22) is a marine pathogen
and a causative agent of vibriosis in larval bivalves (1). Disease is characterized by high
mortality rates leading to severe loss of production in shellfish hatcheries (2-4).
Currently, only two proteases (VtpA and VtpB) and one hemolysin (VthA) have been
characterized in RE22 (5-7). To better understand mechanisms of pathogenicity, it is
necessary to discover additional potential virulence factors. Here we announce the draft
genome sequence of V. coralliilyticus RE22 and selectively describe some potential
virulence factors.
V. coralliilyticus RE22Sm (a spontaneous mutant resistant to streptomycin) was
grown overnight in yeast-peptone broth supplemented with 3% NaCl (YP30) at 27°C in a
shaking water bath. Genomic DNA was isolated using the Wizard Genomic DNA
Purification kit (Promega) according to the manufacturer’s instructions except DNA was
resuspended into 100 μl of a 2mM Tris-HCl, pH 8solution. DNA was sequenced at the
Rhode Island Genomics Sequencing Center using an Illumina MiSeq Sequencer. Reads
were trimmed using the CLC Genomics Workbench (v8.0.1) for quality, ambiguous base
pairs, adapters, duplicates and size resulting in 7,602,646 paired-end and mate-paired
reads averaging 235.84 bp in size. Reads were assembled using the de novo assembly
algorithm of CLC Genomics Workbench and SPAdes Genomic Assembler (v3.1.1) (8).
Contigs with an average coverage above 110 reads were joined using the CLC Microbial
Genome Finishing module using V. coralliilyticus OCN014 as a reference genome. In
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total, the draft genome is composed of five contigs. Three contigs totaling 3.46 Mbp and
having an average G+C content of 46% mapped to chromosome 1 of V. coralliilyticus
OCN014. The complete chromosome 2 is represented by one 1.90 Mbp contig with a
G+C content of 45%. A megaplasmid is represented by one 0.32 Mbp contig with a G+C
content of 50%. The draft genome was annotated using Rapid Annotation using
Subsystem Technology (RAST) and resulted in 5234 open reading frames (9-11).
The genome of V. coralliilyticus RE22 encodes two extracellular metalloproteases
besides the previously described vtpA and vtpB. One protease shows similarity to epp in
Vibrio anguillarum (12) while the other contains a domain conserved in M4 family of
metalloproteases (13-17). In addition to vthA, three putative hemolysin/cytolysin genes
were discovered. A putative MARTX toxin operon encoding three T1SS transport
proteins, a MARTX toxin, and a hypothetical protein is on the megaplasmid. Unlike
typical MARTX toxin gene clusters, the transporter genes are not transcribed divergently
from the MARTX toxin (18). Instead they seem to be in the MARTX operon, upstream
of the MARTX toxin gene. Unlike most MARTX toxin gene clusters, no rtxC
(acyltransferase) is present in the operon. Additional putative hemolysins include a
phospholipase/hemolysin located on chromosome 2 that shows similarity to plp in V.
anguillarum (19) and a hemolysin annotated as hlyA located on chromosome 1 that
shows similarity to vah1 in V. anguillarum (20).
This Whole Genome Shotgun project has been deposited in DDBJ/ENA/GenBank
under the accession no. LGLS00000000. The version described in this paper is the first
version, LGLS01000000.
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Draft genome sequence of the emerging bivalve pathogen Vibrio tubiashii subsp.
europaeus.
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Vibrio tubiashii subsp. europaeus is a bivalve pathogen isolated during episodes of
mortality affecting larval cultures in different shellfish hatcheries. Here we announce the
draft genome of the type strain PP-638 and describe potential virulence factors, which
may provide insight into the mechanism of pathogenicity.

Vibrio tubiashii subsp. europaeus is an emerging bivalve pathogen identified
recently as the etiological agent responsible of larval and spat mortalities in clam, oyster
and abalone cultures detected in Spanish and French hatcheries (1, 2). This pathogen is a
causative agent of vibriosis inducing mass mortalities and important economic losses,
representing the main bottleneck for the production process in shellfish aquaculture (1,
2).
V. tubiashii subsp. europaeus PP-638T (= CECT 8136T= DSM 27349T) was
originally isolated from seawater in a culture tank of flat oyster (Ostrea edulis) during an
episode of larval mortality detected in a shellfish hatchery (Galicia, NW Spain) (1). DNA
was isolated from V. tubiashii subsp. europaeus PP-638T grown up overnight in YP30
using the Wizard Genomic DNA Purification kit (Promega) following the manufacturer’s
instructions except DNA was resuspended in 2mM Tris-HCl Buffer (Bio Basic).
Genomic DNA was sequenced using an Illumina MiSeq at the Rhode Island Genomics
and Sequencing Center at the University of Rhode Island. Reads were trimmed using the
CLC Genomics Workbench (v8.5.1) for quality, ambiguous nucleotides and adapters.
2,943,708 paired-end and 3,234,516 mate-paired reads providing 199× coverage were
assembled using Spades (v3.1.1) using the default parameters (1). Contigs were filter
based on 34× coverage and 4000 bp length resulting in ten contigs with an N50 of
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1,788,614 and an average G + C content of 45.37%. The assembly was mapped to Vibrio
tubiashii ATCC 19109 using the CLC Microbial Genome Finishing module and resulted
in six contigs mapping to chromosome 1, one complete contig representing chromosome
2, one complete contig representing the p251-like megaplasmid and one contig mapping
to the p57-like plasmid (2). One 4,885 bp contig did not map to the reference genome.
The draft genome was submitted to Rapid Annotations using Subsystems Technology
(RAST) for annotation resulting in 5157 open reading frames (3-5).
Encoded on chromosome 2 of the V. tubiashii subsp. europaeus PP-638T genome
is a putative metalloprotease that has a 75% similarity to VtpA found in Vibrio
coralliilyticus RE22 (6). Another protease that has a 71% similarity to Epp in Vibrio
anguillarum M93Sm is encoded on chromosome 2 (7). There are three putative
hemolysins and phospholipases encoded in the genome. One hemolysin located on
chromosome 2 has a 67% similarity to Plp in V. anguillarum M93Sm (8, 9). In V.
anguillarum M93Sm, plp is divergently transcribed from the pore-forming
hemolysin/cytolysin vah1 (9). In V. tubiashii subsp. europaeus PP-638T, the Plp homolog
is also divergently transcribed away from a pore-forming cytolysin, though it has a 42%
similarity to aerolysin in Aeromonas eucrenophila, not vah1 (NCBI Reference Sequence:
WP_042642875.1). The genome encodes two secretion systems (T3SS and T6SS) that
are used to deliver effecter molecules directly into the host. The T3SS secreted virulence
factor has a domain that is similar to the GTPase-activating domain found on YopE from
Yersinia pestis (10-14). While the T6SS structural components are encoded on the p251like megaplasmid, the protein responsible for forming the puncturing tip of the T6SS
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secretion system, VgrG, appears to be encoded by two genes. One VgrG-encoding gene
is on Chromosome 1 and the second is on Chromosome 2.

Nucleotide sequence accession numbers. This Whole Genome Shotgun project has
been deposited in DDBJ/EMBL/GenBank under the accession number LUAX00000000.
The version described in this paper is the first version LUAX01000000.
Acknowledgements. This material is based upon work conducted at a Rhode Island NSF
EPSCoR research facility, the Genomics and Sequencing Center, supported in part by the
National Science Foundation EPSCoR Cooperative Agreement #EPS-1004057 and by
grant AGL2014–59655 from the Ministry of Economy and Competitiveness of Spain.
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